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Abstract 
 
Elevated adipose tissue expression of the Ca
2+
- and voltage-activated K
+
 (BK) channel was 
identified in morbidly obese men carrying a BK gene variant supporting the hypothesis that 
K
+
 channels affect metabolic responses of fat cells to nutrients. To establish the role of 
endogenous BKs for fat cell maturation, storage of excess dietary fat and body-weight (BW) 
gain we studied a gene-targeted mouse model with a global ablation of the BK channel 
(BK
L1/L1
) and adipocyte-specific BK-deficient
 
(adipoqBK
L1/L2
) mice. Global BK deficiency 
afforded protection from high-fat-diet (HFD) induced BW gain and excessive fat 
accumulation. Expansion of white adipose tissue-derived epididymal BK
L1/L1
 pre-adipocytes 
and their differentiation to lipid-filled mature adipocytes in vitro, however, were improved. 
Moreover, BW gain and total fat masses of usually super-obese ob/ob mice were significantly 
attenuated in the absence of BK together supporting a central or peripheral role for BKs in the 
regulatory system that controls adipose tissue and weight. Accordingly, HFD-fed 
adipoqBK
L1/L2
 mutants presented with a reduced total BW and overall body fat mass, smaller 
adipocytes and reduced leptin levels. Protection from pathologic weight gain in the absence of 
adipocyte BKs was beneficial for glucose handling and related to an increase in body core 
temperature due to higher levels of uncoupling protein 1 as well as low abundance of the pro-
inflammatory interleukin-6 as a common risk factor for diabetes and metabolic abnormalities. 
This suggests that adipocyte BK activity is at least partially responsible for excessive BW 
gain under high-caloric conditions suggesting BK channels as promising drug targets for 
pharmacotherapy of metabolic disorders and obesity.  
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Introduction 
Obesity is caused by high calorie intake, typically derived from dietary fats or sugars. Over 
time, an imbalance between nutrient consumption and burning of calories leads to a massive 
increase in fat mass, which among other factors is a major cause of insulin resistance and 
diabetes (1; 2). Additionally, genetic mutations may cause excessive lipid accumulation and 
thereby a morbid gain in body weight (BW) emphasizing the multifactorial etiology of 
chronic excessive weight gain (3; 4). It has become increasingly clear that a variety of K
+
 ion 
channels i.e. K
+
 channels expressed within the brain and in the periphery, possibly by 
complex effects on appetite and satiety, energy expenditure, glucose balance and/or fat cell 
function, are involved in the patho-physiology of obesity and related disorders (5). 
Accordingly, a genome wide association study recently identified the human KCNMA1 gene, 
encoding for the pore forming subunit of the large-conductance Ca
2+
-activated K
+
 channel 
(BK), as a novel susceptibility locus for obesity (6). BK channel mRNA levels in variant-
carriers were significantly increased in white adipose tissue (WAT) and adipose tissue-
derived cells, suggesting a pathogenic role for fat cell BK on metabolism. Others reported 
electrophysiological evidence for BK channels in human pre-adipocytes and BK knock-down, 
or its pharmacological inhibition, further revealed a possible link between channel activity 
and proliferative capacity of these cells (7), whereas Ca
2+
-activated K
+
 channels of the IK 
type seem to be dominant in the widely-studied murine pre-adipocyte model 3T3-L1 (8). 
Because both peripheral and central organs, involved in the control of metabolism, express 
BK it is, however, difficult to estimate the impact of pre-adipocyte BKs on fat cell formation 
and adiposity in vivo. For example, a direct modulation of BK by fatty acids and their 
metabolites seems to provide a possible link between lipid-mediated effects on the channel 
and altered vascular functions in hypertriglyceridemia secondary to obesity (9-13). Previous 
analyses of global BK knock-out mice imply that both glucose-induced insulin secretion and 
endocrine output from the hypothalamic-pituitary-adrenal (HPA) axis, require endogenous 
BK channels (14; 15). However, it has not been determined whether these dysregulations in 
β-cell or HPA function caused metabolic abnormalities in vivo (16). Moreover, several studies 
find BK promote inhibitory effects of leptin signaling, via PI3-kinase in hippocampal neurons 
(17) and in mouse chromaffin cells (18), suggesting that neuronal circuits controlling appetite 
and energy expenditure may also depend on functional BK. A malfunction of neuronal 
circuits has been widely appreciated as causing excessive fat storage (19) and a number of 
studies, indeed, found evidence for BK in brainstem, different hypothalamic nuclei, parts of 
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the cortex and limbic system, hence in brain regions that are implicated in the central control 
of food intake, appetite and energy expenditure (20; 21).  
The recent discovery of functional channels with properties similar to BK in fat cell 
progenitors (7) together with the link between high fat cell BK mRNA expression levels and 
morbid adiposity (6) suggest that BK activity in the adipose tissue plays, yet to be discovered, 
physiologically and pathophysiologically important roles for weight control. In order to 
establish endogenous BK channels as potential modulators of fat deposition and excessive 
weight gain we herein assessed the susceptibility of global and adipocyte-specific BK mouse 
mutants towards genetic- and dietary-induced causes of adiposity. Our approach to validate 
BK as a novel player in the response to obesogenic factors in vivo should also direct future 
studies on the pharmacotherapy of adiposity and related disorders.  
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Research design and methods  
Animals and diets. All animal experiments were performed with permission of the local 
authorities and conducted in accordance with the German legislation on the protection of 
animals. Animals were housed in cages under controlled environmental conditions with 
temperatures maintained between 21-24°C, humidity at 45-55% and 12h light-dark-cycle.  
Global BK channel deficient mice (genotype: BK
L1/L1
), heterozygous (genotype: BK
L1/+
) and 
wildtype littermates (genotype: BK
+/+
) on a C57BL/6N background were generated and 
maintained at the Institute of Pharmacy, Department of Pharmacology, Toxicology and 
Clinical Pharmacy, University of Tübingen as described previously (22). To produce BK
L1/L1
 
mice which are also unable to produce functional leptin (genotype: BK
L1/L1
; B6.V-Lep
ob/ob
 
(BK
L1/L1
; ob/ob)) BK
L1/+ 
animals were crossed to mice carrying a heterozygous mutation of the 
leptin-gene B6.V-Lep
+/ob
 J (ob/+) obtained from Charles River, Germany. Intercrossing of 
double-heterozygous animals (genotype: BK
L1/+
; B6.V-Lep
ob/+
 (BK
L1/+
; ob/+)) produced 
homozygous obese BK
L1/L1
; ob/ob, obese BK
+/+
 (genotype: BK
+/+
; B6.V-Lep
ob/ob
 (BK
+/+
; 
ob/ob)), lean BK
L1/L1
 (BK
L1/L1
; B6.V-Lep
+/+ 
(BK
L1/ L1
; +/+)) and lean BK
+/+ 
(BK
+/+
; B6.V-
Lep
+/+  
(BK
+/+
; +/+)) offspring from the same litters. In order to obtain tissue-specific mutants 
lacking BK in various adipocyte populations heterozygous BK mice (BK
L1/+
) on C57BL6 
background, carrying a tamoxifen inducible adipose tissue-specific Cre recombinase 
(genotype: adiponectin-CreERT2
tg/+
) under control of the adiponectin promoter (23), were 
first mated to homozygous floxed BK animals (genotype: BK
L2/L2
). Adipocyte-specific 
controls (genotype: adiponectin-CreERT2
tg/+
; BK
+/L2
 (adipoqBK
+/L2
)) and pre-mutant BK 
animals (genotype: adiponectin-CreERT2
tg/+
; BK
L1/L2 
(adipoqBK
L1/L2
)) derived from this 
breeding were injected with tamoxifen (1 mg/d) for 5 consecutive days to induce Cre-
mediated recombination at an age of 8 weeks (Fig. 3 and Fig. 4C-H) or 19 weeks (Fig. 4I).  
The specificity and efficiency of the adiponectin-CreERT2-derived recombination 
 
was 
supported by studying double fluorescent ROSA26-Tomato reporter mice (genotype: 
ROSA26
mTomato/mEGFP
 ((tom/+)) obtained from Charles River, Germany (24) expressing the 
adipoqCreERT2 transgene (genotype: adiponectin-CreERT2
tg/+
; ROSA26-Tomatotom/+; 
(adipoq
tg/+
; tom/+). Double-transgenic animals were either injected with tamoxifen for 5 days 
as described to induce recombination of the reporter allele i.e. a switch from cell membrane-
localized red fluorescence to green fluorescence proteins or received solvent. Genotyping was 
performed using specific primers to identify the Cre transgene (23), the single nucleotide 
mutation in the leptin gene (according to a protocol for Stock Number: 000632 by The 
Jackson Laboratory) and the L1, L2 and wild-type alleles of the BK on DNA samples 
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obtained either from different fat depots, control tissue or tail-tip biopsies from mice that were 
left untreated or received tamoxifen as described previously (22).  
Prior to the different research diets, all experimental mice received tap water and a 
commercial chow obtained from Altromin, Germany ad libitum. Dietary feeding trials were 
performed in male mice that were allowed to adapt to a defined control-diet (CD) formulation 
containing 10% of calories due to fat for two weeks prior the long-term feeding experiments. 
With 10 weeks of age experimental mice either received a high-fat-diet (HFD) containing 
45% or 60% of calories due to fat or were continued to feed the CD for another 18 weeks. 
Progressive body weight gain in the monogenetic model of obesity was monitored between 4 
and 24 weeks of age on normal chow diet. 
 
Food intake and body core temperature measurements 
The core body temperature and the locomotor activity were measured by using a telemetry 
setup (ETA-F10 with the two-lead ECG transmitters of the implant removed because they 
were not required for monitoring the activity and temperature; Data Sciences, Inc.). The 
surgical procedure was described previously (25). In brief, anesthesia was induced by a 4% 
isoflurane in oxygen inhalation and was then maintained with 1-2% isoflurane. By aseptic 
technique the implants were placed in the peritoneal cavity and the skin was closed with a 5/0 
surgical silk. During recovery, mice were placed on a warming pad before they were returned 
to their home cages for at least 3 days before recordings were started. Activity and body core 
temperature were assessed continuously for 96 hours in experimental mice that had received 
the HFD diet for 18 weeks. 
Food intake was measured using a non-automated and modified metabolic cage setup. To 
reduce the environmental stress in the feeding chamber of the metabolic cage mice housed 
individually were placed on paper bedding that was renewed daily. After two days of 
acclimatization food consumption was assessed for 4 days using an analytic balance. Foot 
pellets were replaced every 24 hours. The amount of food consumed by each individual 
mouse was determined by calculating the weight differences between the initial weight of the 
pellets and the final pellet weights 24 hours later. Food pieces dropped by the animals on the 
paper bedding were thoroughly collected and included in the final weight determination. Food 
intake was assessed in a subset of experimental mice prior the dietary feeding at an age of 10 
weeks or after the CD or HFD feeding protocols. 
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Growth and maturation of pre-adipocytes in vitro. Pre-adipocytes derived from iWAT or 
eWAT of 10 week old BK
+/+
 and BK
L1/L1
 mice were isolated by an established collagenase 
liberation protocol (26). Upon 50 min of digestion in Collagenase type I/HEPES buffer at 
37°C, 2x10
4 
or 5x10
4 
cells/cm² from iWAT or eWAT were plated in DMEM-Ham’s F12 with 
5% FCS, respectively. At 90-100% cell confluency maturation was induced by addition of 
induction medium containing insulin (170 nM), dexamethasone (1 µM), 
isobutylmethylxanthin (500 µM) and indomethacine (30 µM) to eWAT cultures. 
Differentiation of iWAT pre-adipocytes was stimulated by adding rosiglitazone (2.5 µM) and 
triiodothyronine (1 nM) to the eWAT induction medium. After 48h of induction the medium 
was exchanged by insulin (170 nM) containing medium in DMEM-Ham’sF12 with 10% FCS 
for another 48h, followed by maintenance medium (DMEM-Ham’sF12 with 10% FCS). 
Maintenance medium was changed every second day until cells were mature, usually 14 to 16 
days after plating. Triglyceride-incorporation was detected by Oil-red-O (ORO) staining. 
ORO-content was quantified by photometry using the Implen-system at 518 nm. Digital 
images of the maturation process were acquired using AxioVision software version 4.8 (Carl 
Zeiss, Jena, Germany). Cell-growth and proliferation assays were analyzed in real-time using 
the xCELLigence impedance setup (OMNI life science, Bremen, Germany) during the first 60 
hours upon plating in DMEM-Ham’sF12 with 5% FCS medium. Data was acquired and 
analyzed using the RTCA software version 1.2.1 (ACEA Biosciencis Inc.). 
 
Electrophysiological recordings. The conventional whole-cell mode of patch clamp 
electrophysiology was used to analyse BK currents in undifferentiated and differentiated 3T3-
L1 cells as well as from pre-adipocytes and induced matured adipocytes prepared from 
primary cultures of mouse eWAT. The pipette solution contained 140 mM KCl, 10 mM 
HEPES, 30 mM Glucose, 1 mM BAPTA, 2 mM MgCl and free calcium buffered to 0.5µM at 
pH 7.2. The standard bath (extracellular) solution contained (in mM): 140 mM NaCl  5 mM 
KCL  10 mM HEPES, 20 mM Glucose, 2 mM MgCl and 1 mM CaCl and pH was adjusted to 
7.4. Electrophysiological recordings were performed at room temperature (18-22°C) using 
pCLAMP 9 (Molecular Devices) with a sampling rate of 10 kHz and filtered at 2 kHz. Patch 
pipettes were fabricated from borosilicate glass (Garner) with resistances between 2-3 MΩ. 
Drugs were applied to cells using a gravity perfusion system with a flow rate of 1-2 ml/min to 
minimise flow-induced artefacts. For analysis of BK currents, the BK channel specific 
blocker paxilline (1µM) was applied and the paxilline-sensitive outward current analysed at 
the membrane voltages indicated in the respective figure legends. 
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Adipose tissue histology. For histological examination tissues were fixed in 4% 
paraformaldehyde for 1.5 hours directly after harvesting and were then embedded in NEG 
50™ (Richard-Allan Scientific, Thermo Scientific) for sectioning following sucrose-gradient 
cryoprotection. Serial 14-µm cryo-sections of different WAT depots were prepared using a 
HM 560 cryostat (Thermo Scientific, Waltham, USA) and stored at -80°C until further 
processing. To determine the size of the fat cells prior to and after different diets their 
perimeter was determined in digital images of the iWAT depot using the AxioVision software 
package version 4.8 (Carl Zeiss, Oberkochen, Germany). The uncoupling protein 1 (UCP1) 
expression pattern was compared between iWAT cryo-sections obtained from HFD-fed 
adipoqBK
L1/L2 
and adipoqBK
+/L2 
mice using a commercial antibody (Santa Cruz, Dallas, USA) 
(dilution 1:400). BK immunodetection was performed in iWAT and eWAT sections derived 
from 10-week old global and adipocyte-specific BK mutants and control litters using a 
primary antibody, specific for the BK channel alpha subunit (dilution 1:1000) and hormone-
sensitive lipase (HSL; dilution 1:400) according to a previously published protocol (27). In 
brief, antigen-antibody-complexes were detected by a fluorescense-labeled secondary 
antibody (AlexaFluor®568; anti-rabbit) (dilution 1:500) using the AxioCam MR system (Carl 
Zeiss, Oberkochen, Germany) or by appropriate secondary antibodies conjugated to 
horseradish peroxidase (dilution 1:500). 
 
Adipose tissue mass and total body composition. To determine total fat mass and individual 
mass of different depots fat pads were dissected unfixed upon dietary-feeding then weighed, 
immediately immersed in liquid nitrogen and finally stored at -80°C for further analysis. For 
total body-composition analysis total body weight was determined prior and after drying the 
corpse for 24 hours at 85°C. Water content was calculated as difference between dry and total 
weight. Fat-content was determined in dried corpses using the Soxhlet procedure according to 
a previously published protocol (28). 
 
Blood parameters and glucose tolerance test. Blood was collected from mice prior to or 
after dietary feeding. Leptin, IL-6 and adiponectin levels were measured in serum samples 
with mouse immunoassay kits (Merck Millipore, Darmstadt, Germany) according to 
manufacturer’s instructions. Blood glucose was determined using the GlucoCheck advance 
system (TREND Pharma GmbH, Saalfeld/Saale, Germany) immediately before i.p. glucose 
challenge (2 g/kg of body-weight) as well as 15, 30, 60 and 120 min after the injection in 
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over-night fasted mice. At each time additional blood (25 µl) was collected via the tail vein 
for subsequent insulin determination. Plasma-Insulin was measured using the Ultra Sensitive 
mouse Insulin ELISA (Mercodia, Uppsala Sweden), according to manufacturer’s instructions. 
 
mRNA expression analysis. Total mRNA was extracted from WAT samples by a 
guanidineisothiocyanat-phenol-chloroform extraction protocol using PegGold RNA Pure 
(Peqlab Biotechnologie, Erlangen, Germany) according to the manufacturer’s instructions. 
Following DNase treatment for 30 min to remove traces of genomic DNA, RNA samples 
were quantified and 0.5 µg RNA were used to generate cDNA using the ISRIPT cDNA 
synthesis kit (Bio-Rad, Hercules, USA). Quantitative real-time PCR was performed in 
triplicates using the comparative 2
−∆C(t)
 method, with C(t) indicating the cycle number at 
which the signal of the PCR product crosses the threshold, set within the exponential phase of 
the detected fluorescence signal. BK- and IL-6-levels were normalized to β-actin to determine 
their relative quantitates. The respective primer sequences designated were: BK forward: 5’- 
GAC GCC TCT TCA TGG TCT TC -3’, BK reverse: 5’-TAG GAG CCC CCG TAT TTC 
TT-3’; IL-6 forward: 5’- CTT CAA CCA AGA GGT AAA AG -3’, IL-6 reverse: 5’-CCA 
GCT TAT CTG TTA GGA GAG -3’. For extraction of total mRNA from 3T3-L1 cells or pre-
adipocytes and differentiated adipocytes in culture the Roche High pure mRNA extraction kit 
was used according to the manufacturer’s instructions following shearing of cells in lysis 
buffer using a 25G needle. Following DNase treatment as above 0.25 µg RNA were used to 
generate cDNA using the Roche Transcriptor Hi-Fidelity cDNA synthesis kit with random 
hexamers and oligo-dT used at a 2:1 ratio. qRT-PCR was performed using the comparative 
2
−∆∆C(t)
 method as above with mRNA levels normalized to Ipo8. The respective primers were: 
BK forward: 5’-GTC TCC AAT GAA ATG TAC ACA GAA TAT C; BK reverse primer: 5’-
CTA TCA TCA GGA GCT TAA GCT TCA CA; GLUT4 using the Quantitect Assay 
(Mm_Slc2a4_2_SG) and Ipo8 using Quantitect assay (Mm_Ipo8_2_SG) from Qiagen.  
 
3T3-L1 culture and differentiation. Undifferentiated (UD) 3T3-L1 fibroblasts were 
maintained in Dulbecco’s modified Eagle’s Medium (DMEM) containing 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin at 37
o
C at 10% CO2 and passaged every 4 days 
after reaching 60-80% confluency. Differentiation was initiated in confluent monolayers in 
DMEM/FBS containing 1µg/ml insulin, 0.25µM dexamethasone, 1µM troglitazone and 
500µM IBMX for 3 days followed DMEM/FBS containing 1µg/ml insulin and 1µM 
troglitazone. After 3 days cell medium was replaced with DMEM/FBS and medium refreshed 
Page 9 of 76
For Peer Review Only
Diabetes
Illison et al. Adipocyte BK protects from overwhelming BW gain 07/24/2016 
10 
 
every 3 days until differentiated cells (DF) were analysed (typically 10-14 days after initiation 
of differentiation). 
 
Immunoblot analysis of iWAT and 3T3-L1 derived protein lysates. Inguinal WAT was 
dissected and processed as described in order to generate total protein lysates for subsequent 
immunoblot analyses (27). Total protein was obtained from undifferentiated and differentiated 
3T3-L1 fibroblasts. Separation of the proteins by molecular weight was done by gel 
electrophoresis using 12% SDS gels. For immunodetection primary UCP1 (Santa Cruz, 
Dallas, USA) (dilution 1:1000), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
dilution 1:1000) (Cell Signaling), glucose transporter type 4 (GLUT4, 1:1000) (generous Gift 
from Gwyn Gould, Glasgow, UK), BK (1:1000) (NeuroMab, UC Davis, USA) and β-actin 
(1:500) (Sigma-Aldrich, St. Louis, USA) antibodies were used. 
 
Statistical analysis. Statistical analysis was performed on experimental data using a two-
tailed student’s t-test for paired or unpaired comparison or ANOVA with post-hoc Dunnett’s 
test for multiple comparisons where appropriate. All data are presented as mean ± SEM. For 
all tests, p-values less than 0.05 were considered as significant: P<0.05 (*), P<0.01 (**), 
P<0.001 (***). 
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Results 
Body weight (BW) gain was investigated in global BK-deficient (BK
L1/L1
) and age- and litter-
matched male wild-type mice (BK
+/+
) (Fig. 1A) receiving either a purified low-fat control 
(CD) or a high-fat diet (HFD). Prior to the different diets we observed a small but highly 
significant (P<0.001) difference in the BWs between the two genotypes as previously 
reported (29; 30). Starting with 5 weeks of HFD feeding, however, a substantial weight gain 
in male BK
+/+ 
mice became apparent resulting in a total BW gain of 16.44 ± 0.83 g for BK
+/+ 
mice at the end of a 18 weeks HFD feeding protocol (Suppl. Fig. 1A), whereas BK
L1/L1
 
mutants gained 8.37 ± 0.45 g in the same observation period. Importantly, the differences in 
BW gain of BK
L1/L1 
mutants were about than 10 % for CD (33.34 ± 2.38%) and HFD (44.26 ± 
2.68%) fed groups, whereas the respective difference in the diet induced BW gain for BK
+/+ 
mice was 27.76% (Suppl. Fig. 1B). Neither daily food intake of BK
+/+ 
and BK
L1/L1 
mice under 
CD- or HFD-fed conditions (Suppl. Fig. 1C) nor the activity or body-temperature of the 
animals differed significantly (Suppl. Fig. 1D-E) under HFD suggesting that the lean 
phenotype of the BK
L1/L1
 mice was, at least not primarily, due to abnormal hyperactivity or 
dysfunctions in central control of peripheral circuits regulating food intake and reward 
behaviors. Body-composition revealed that the HFD feeding did not affect wet body mass and 
carcass dry mass but rather stimulated a substantial increase in the total body fat mass in 
BK
+/+ 
mice, whereas the respective body-composition of CD- and HFD-fed BK
L1/L1 
did not 
differ (Fig. 1B) supporting the notion that the genotype-specific differences in BW upon CD 
and HFD feeding (Fig. 1A) are largely due to reduced accumulation of fat in the absence of 
BK. Less total body fat mass of CD- and HFD-fed BK
L1/L1 
mice
 
were accompanied by a small 
but significant shift to lower dry mass values and reduced tibial length (TL) (Suppl. Fig. 1F) 
both confirmatory for the lower overall body size in the global absence of BK channels (Fig. 
1C). Analyses of fat mass-normalized to TL revealed significant weight differences for 
various white adipose tissue (WAT) depots as well as the interscapular brown adipose tissue 
(BAT) indicating that the lean phenotype of the BK
L1/L1 
mice was related to a decrease in 
multiple adipocyte tissue cell populations (Fig. 1D). So far, the data suggest that high-caloric 
nutrition-induced BW gain requires functional BK channels. Additionally, the reduced TL, in 
the global BK knock-outs is in accordance with previous reports collectively implying a mild 
growth defect that may contribute, at least partly, to the differences observed between BK
+/+ 
and BK
L1/L1
 BW during dietary feeding (30). We next tested whether BK plays a role for the 
excessive fat accumulation in the monogenic ob/ob model of morbid obesity. BW gain 
(Suppl. Fig. 2A), body-composition (Suppl. Fig. 2B+C) and individual weights of different fat 
Page 11 of 76
For Peer Review Only
Diabetes
Illison et al. Adipocyte BK protects from overwhelming BW gain 07/24/2016 
12 
 
depots (Suppl. Fig. 2D) were studied in BK-negative ob/ob double-mutants and age- and 
litter-matched ob/ob controls. In line with the HFD-fed BK
+/+
 and BK
L1/L1
 mice we find that 
key parameters of the progressively developing super-obese phenotype, including body 
weight, body-composition and fat depot masses are attenuated in the absence of BK (Suppl. 
Fig. 2A-D). In contrast, differences in BW gain between lean control mice in the absence 
(∆16.83 ± 0.55 g) and presence (∆15.73 ± 0.55 g) of BK were not significant (p = 0.17). 
Protection against overwhelming BW gain in the BK-deficient ob/ob model was related to a 
consistent effect on total fat masses and non-fat components of the body (Suppl. Fig. 2B). 
Indeed, a lower initial as well final BW of BK-negative lean and ob/ob double-mutant mice 
(Suppl. Fig. 2A) as well as differences in the mean TL (Suppl. Fig. 2E) suggest that BK plays 
a role for normal growth development (Suppl. Fig. 2) and morbid obesity resulting from leptin 
deficiency. 
Based on previous reports on the role of K
+
-channels in adipocytes (6; 7) and our consistent 
observation of lower fat masses of multiple fat depots (Fig. 1D and Suppl. Fig. 2D) we 
considered that the protection from overwhelming weight gain was stemming from the 
adipocyte itself. To address this possibility, we first assessed the BK mRNA and protein 
expression in inguinal and epididymal white adipose tissue (iWAT and eWAT, respectively). 
Fat pads were studied using primer pairs allowing for specific detection and quantification of 
BK mRNA (Fig. 1E+F). As compared to the internal reference BK levels in BK
+/+ 
iWAT and 
eWAT depots were low but reliable amplification was accomplished in all samples tested. 
Importantly, signal traces detected in the respective fat depots derived from BK
L1/L1 
mice were 
well in the range of non-specific PCR product formation in the absence of reverse 
transcriptase (Suppl. Fig. 3A+B). Because adipose tissue is heterogeneous, composed of fat- 
and non-fat cells, we next examined the cellular distribution of BK channel protein in frozen 
adipose tissue sections obtained from 10 week old BK
+/+ 
and BK
L1/L1 
mice. These analyses 
revealed evidence for BK in unilocular BK
+/+ 
cells, characteristic of white adipocytes, 
whereas BK
L1/L1
 iWAT and eWAT remained BK-negative (Fig. 1G+H). Importantly, our 
specific BK antibodies and an antibody for the white fat cell marker hormone-sensitive lipase 
(HSL) marked the same cells in BK
+/+ 
eWAT (Suppl. Fig. 3C) supporting the notion that 
mature adipocytes express BK channels.  
 
To explore the functional attributes of endogenous BK channels in adipocytes we adopted a 
previously established protocol of primary culture and differentiation of murine adipocyte 
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precursor cells (26). Adipocyte differentiation was induced at 90-100% confluence of BK
+/+ 
and BK
L1/L1 
precursor cells derived either from eWAT and iWAT depots. Oil-red-O (ORO) 
incorporation into lipid droplets revealed strong accumulation of lipid-filled adipocyte-like 
cells under adipogenic maintenance conditions in cell cultures derived from both BK-negative 
and BK
+/+ 
eWAT (Fig. 2A-C) and iWAT (Fig. 2D-F). In iWAT-derived cultures we did not 
observe differences in the adipogenic differentiation among genotypes (Fig. 2D-F), whereas 
the amount of ORO incorporation was significantly higher in BK
L1/L1
 than BK
+/+ 
cultures 
established from
 
eWAT (Fig. 2A-C) suggesting a depot-specific role for BK on in vitro lipid-
storage. Moreover, genetic and pharmacological blockade of BK channels enhanced the 
growth of eWAT-derived pre-adipocytes (Fig. 2G+H).  
To further validate differentiated adipocytes from eWAT express functional BK channels, we 
assayed BK mRNA, protein and ionic currents in the differentiated cultures. BK channel, as 
well as GLUT4 transporter, mRNA and protein were strongly upregulated in differentiated 
cells compared to precursor cells (Fig. 2I+J). Importantly, outward potassium currents, 
sensitive to the specific BK channel blocker paxilline (1 µM), were significantly upregulated 
in differentiated adipocytes (Fig. 2K). An increase in BK channel mRNA, protein and 
currents were also observed in the established 3T3-L1 pre-adipocyte cell model following 
induction of differentiation (Suppl. Fig. 4A-C). In addition, inhibition of BK channels with 
paxilline increased the growth of 3T3-L1 pre-adipocytes and the amount of ORO 
incorporation into lipid droplets (Suppl. Fig. 4D+E). Taken together, these data suggest that 
fat cell BK channels control pre-adipocyte expansion and adipogenic conversion of pre-
adipocytes in an adipocyte depot specific manner.  
Because homeostasis of mature adipocyte and adipocyte differentiation in vivo are distinct 
from the above studied in vitro models, we next studied the lean phenotype by generating an 
adipocyte-specific BK knock-out mouse model (adipoqBK
L1/L2
). In a first series of 
experiments we confirmed the tissue-specific recombination efficacy of the recently 
established adiponectin promotor-driven tamoxifen-inducible CreERT2 mouse model (23) 
using a two-color fluorescent Cre reporter system (24). Prior to Cre-mediated excision we 
observed ubiquitous expression of a cell membrane-targeted red fluorescent Tomato (mT) in 
eWAT, iWAT and all other tissues studied suggesting that the ROSA
mT/mG
 mouse is indeed a 
global Cre reporter model (Fig. 3A+B and data not shown). Tamoxifen induced Cre-mediated 
excision of the floxed mT was leading to an almost complete switch to green fluorescent 
protein (mG) expression in eWAT and iWAT fat cells, whereas changes in mT labelling were 
not observed in various other organs such as brain, skeletal muscle, and liver (data not 
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shown). High efficiency and specificity of the adiponectin-CreERT2 approach was further 
confirmed by a BK specific primer set designed to identify the three different BK alleles i.e. 
wild-type (+), floxed (L2) and knock-out (L1) within one sample. In line with the Cre-reporter 
assay (Fig. 3A+B) PCR products indicative of a recombination event were only observed in 
white and brown adipocyte tissues of adiponectin-CreERT2 transgenic BK
+/L2
 mice 
(adipoqBK
+/L2
), whereas analysis of multiple other cell types and organ systems did not reveal 
significant Cre activity regardless of whether tamoxifen was applied or not (Fig. 3C). As 
compared to adipoqBK
+/L2 
controls,
 
eWAT and iWAT
 
BK mRNA expression levels were 
reduced in tissue-specific adipoqBK
L1/L2 
mutants upon tamoxifen application (Fig. 3D). 
Accordingly, adiponectin-CreERT2 activation by tamoxifen resulted in a nearly complete 
ablation of the BK protein in the different WAT tissues (Fig. 3E+F). Hence, the adipocyte-
specific knock-out model of BK should allow us to test the role of fat cell BK channels for 
BW gain under CD- and HFD-feeding conditions in the absence of changes in satiety or 
adiposity signals arising from endocrine or neuronal circuits potentially involving 
hypothalamic BK channels among others. To induce site-specific recombination of the L2 BK 
gene locus, adipoqBK
L1/L2 
mice as well as adipoqBK
+/L2 
control age- and littermates were 
subjected to the tamoxifen injection 2 weeks prior to the experimental diets i.e. a CD or a 
HFD with 60% of its calories derived from fat (Fig. 4A+B). Consistent with our previous 
findings in the global BK
L1/L1 
model (Suppl. Fig. 1C), the tissue-specific ablation of BK did 
not affect the amount of CD or HFD food consumed by the animals at the start or end of the 
feeding experiment (Fig.4C+D). Starting BWs and BW gain in the CD group were not 
different between adipoqBK
+/L2 
and adipoqBK
L1/L2 
mice (Fig. 4E+G), whereas lack of 
adipocyte BK channels afforded partial protection against HFD-induced gain in BW (Fig. 
4F+H), an effect that reached the significance level after 4 weeks of HFD-feeding and was 
maintained until the mice reached their final BWs (Fig. 4F) indicative for a lower 
susceptibility of adipoqBK
L1/L2 
mutant mice towards high caloric challenges. We next tested 
whether excess BW gain is also affected by fat cell BK in mice which have already 
established significant weight gain. To test this, tamoxifen treatment was commenced at an 
age of 19 weeks when the adipoqBK
+/L2 
control and adipoqBK
L1/L2 
pre- mutants had reached a 
BW of 32.35 ± 1.05 g and 31.91 ± 0.89 g, respectively. Total BW gain was not different 
between age-and litter-matched adipoqBK
+/L2
 and adipoqBK
L1/L2 
mice prior to the tamoxifen 
treatment (t10-19 8.18 ± 1.00 g for adipoqBK
+/L2 
and t10-19 7.71 ± 0.76 g for adipoqBK
L1/L2 
(P = 
0.7)), whereas upon five repetitive tamoxifen injections the extent of the weight gain showed 
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a clear tendency towards lower values in adipoqBK
L1/L2 
 mice (Fig. 4I) (t20-30 5.33 ± 0.56 g for 
adipoqBK
L1/L2
  and t20-30 7.40 ± 1.03 g for adipoqBK
+/L2 
(P<0.06))  
In depth analyses of the individual fat depots (Fig. 5A+G) and the total fat mass (Fig. 5B) did 
not reveal statistical weight differences between adipoqBK
+/L2 
and adipoqBK
L1/L2 
fed a CD 
diet. HFD feeding, however, confirmed protection from excessive fat storage in adipoBK
L1/L2 
mice. Interestingly, lack of adipocyte BK was associated with lower total fat masses and 
lower masses of various fat depots (Fig. 5C-G). Because fat mass is determined by both 
adipocyte number and size we next studied fat storage at the cellular level. Inguinal WAT cell 
size was calculated by assessing the cell perimeters in different cryo-sectional areas obtained 
from adipoqBK
+/L2 
and adipoqBK
L1/L2 
mice. Prior to the different diets i.e. at an age of 10 
weeks genotype-specific differences in fat cell size were not detectable in different areas of 
the iWAT sections (Fig. 6A+C). As compared to adipoqBK
+/L2
 fat cells,
 
BK-deficient 
adipocytes were smaller upon CD and HFD feeding (Fig. 6A+C). Because enlarged, 
hypertrophic fat cells in the adipose depot relate to obesity, inflammation and insulin 
resistance we next tested whether the observed changes in adipocyte morphology (Fig. 6A-C) 
associates with a more proinflammatory state. Indeed, we find reduced IL-6 mRNA 
expression in iWAT of HFD-fed adipoqBK
L1/L2 
mice and tendentially lower serum IL-6 levels 
(Fig. 6E; p = 0.11). Moreover, HFD-fed adipoqBK
L1/L2 
mice exhibited lower serum leptin 
levels as a marker of body-mass (Fig. 6F), whereas adiponectin concentrations were not 
different between diets or genotypes (Fig. 6G). In accordance with the markers of 
inflammation, low adipose tissue mass and fat cell hypertrophy, adipoqBK
L1/L2 
mice showed
 
an improved glucose clearance (Fig. 6H) with lower insulin levels (Fig. 6J) upon intra-
peritoneal glucose challenge after HFD-feeding, whereas lack of adipocyte BK did not affect 
glucose handling prior to the feeding protocol (Fig. 6I). Change in cellularity of the iWAT 
may also be taken as an indicator for accelerated browning to promote energy expenditure 
which will counter obesity and its metabolic consequences. Lack of fat cell BK resulted in 
strong induction of the uncoupling protein 1 (UCP1) (Fig. 7A+C) as a hallmark of uncoupled 
respiration and heat production by brown or brown adipocyte-like fat cells. Higher levels of 
UCP1 protein under HFD-fed conditions were also reflected by a significant increase in core 
body temperature during the night (Fig. 7D), whereas during the day, while the mice were 
sleeping, body temperatures of adipoqBK
L1/L2
 and adipoqBK
+/L2
 mice were lower suggesting a 
reduced burning of stored fats with no apparent differences between the two genotypes (Fig. 
7D). 
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In summary, adipocyte BKs promote fat cell size and fat pad mass in vivo. Adipocyte tissue 
growth in the presence of endogenous BK channels was related to a noninfectious activation 
of adipose tissue inflammation and metabolically unfavourable effects on fat cell functions, 
which together may result in insulin resistance and amplified HFD-induced adiposity. 
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Discussion 
By our combined analysis of different BK channel mutant mouse lines we have uncovered a 
novel function for adipocyte BKs in fat cell biology and metabolism under different 
nutritional conditions. We find resistance to HFD-induced BW gain, lower total fat mass and 
thereby improved glucose handling upon ablation of endogenous BK channels in adipose 
depots in different parts of the body. These data imply that the development of obesity caused 
by nutrient excess is promoted by the BK channel (Fig. 4). Accordingly, a previously 
identified BK gene variant was associated with elevated levels of fat cell BK mRNA in 
morbidly obese human subjects suggesting a causal relationship between the amount of 
adipocyte BKs and weight gain (6). To the best of our knowledge, BK levels in other organ 
systems of the affected patients have not been assessed; therefore, it remains unclear if the 
obesogenic effects attributed to amplified BK expression resulted exclusively from an effect 
on adipocyte cell function or whether BK channels present in non-adipocyte cells contributed 
to morbid weight gain. Interestingly, our HFD-fed BK
L1/L1 
mutants did not exhibit any 
changes in dietary food consumption or body temperature (Suppl. Fig. 1C+D), whereas the 
respective fat-cell specific mutants exhibited a lean phenotype that was related to an increase 
in UCP1 levels and energy expenditure (Fig. 7). It therefore seems tempting to speculate that 
BK channels in the brain or other non-fat cells dot no play a role for the chemical and neural 
signals regulating calorie intake and/or energy expenditure and thereby body composition. For 
several reasons, however, we find it is too early to draw such conclusions:  
i.) Our previous analyses of the global BK
L1/L1
 mouse model revealed multiple defects in 
various systems of these animals including in β-cells (15), the HPA-axis (14) and cerebellar 
neurons (29), which separately or together could affect energy balance and BW development. 
For example, lack of cerebellar BK channels in Purkinje cells, among other deficits, was 
shown to cause motor learning impairment and signs of ataxia with the latter being related to 
muscle shivering and trembling (29), a common cause for increased energy expenditure. 
Irrespective of the dietary fat content we did not observe an increase in the body core 
temperatures of BK
L1/L1 
mice (Suppl. Fig. 1D) suggesting that their very low body-fat content 
(Fig. 1) allow them to keep body temperature at physiological levels. Potential changes in 
body temperature regulation i.e. adjustments due to changes in non-/shivering thermogenesis 
may be superimposed by the loss of heat in BK
L1/L1
 mutants. Yet, BK
L1/L1
 mice present with a 
lean phenotype with CD and HFD feeding regimes and we observed a lower propensity of the 
BK/ob double mutants to accumulate excessive body weight and fat mass. This suggests that 
the global lack of BK channels for the entire lifespan prevents the excessive BW gain, an 
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effect that was more obvious in the presence of genetic or nutritional risk factors for obesity 
development. In this complex mouse model, a dysregulation of multiple pathways (in fat 
cells, hypothalamus, liver, sympathetic neurons, β-cells, etc.) involving BK may be related to 
this phenotype. 
ii.) The protection in terms of BW gain and fat accumulation was less pronounced in 
adipocyte specific BK knock-out groups as compared to the BK
L1/L1
 or BK/ob double mutant 
models (compare Fig. 1A, Suppl. Fig. 2A and Fig. 4F) implying non-fat cell BKs are also 
important for weight control in vivo. Indeed, dietary-related changes in energy expenditure 
involving, for example, hypothalamic control mechanisms may be positively or opposingly 
regulated by BK channels of neuronal nuclei that respond to satiety or hunger signals. Lack of 
GIRK4, a G protein-gated inwardly rectifying K
+
-channel, in mice, for instance, resulted in 
late onset obesity through hypothalamic mechanisms (31), whereas ATP-sensitive K
+
 channel 
(KATP) knock-out mice showed hyperphagia but were resistant to HFD induced BW and 
visceral fat mass gain (32). Along these lines, KATP conductance in diet-induced obesity has 
been reported in pro-opiomelanocortin positive nuclei of the hypothalamus, and neuronal 
excitability and thereby the release of peptides that control food intake and BW were sensitive 
to central KATP inhibition (33). In addition to KATP, BK channels have been shown to modulate 
the excitability of hypothalamic neurons in response of insulin and leptin under physiological 
conditions (34) suggesting they may be involved in central circuits regulating BW via energy 
intake and expenditure. Given the complexity of the different metabolic pathways future 
studies are needed to clarify the functional roles of hypothalamic and other non-fat cell BK 
channels in adiposity and thereby the mechanism(s) underlying the lean phenotype of BK
L1/L1
 
mice. Resistance to genetic and diet-induced models of obesity i.e. hypothalamic-driven 
obesity has also been reported in mice with a Shaker family voltage-dependent K
+
 channel 
gene disruption in Kv1.3 (35; 36), further highlighting the importance of K
+
 channels for the 
hypothalamic-regulation of BW (37). More recently, however, therapeutic benefits on obesity 
and insulin resistance upon Kv1.3 inhibition by using a blocker which was unable to cross the 
blood–brain barrier have been attributed to peripheral mechanisms stemming from changes in 
liver and WAT metabolism and brown adipose tissue (38). Obviously, peripheral and central 
K
+
-channels affect the development of adiposity.  
Studying adipocyte-specific BK knockout mice, we did not find any evidence for tamoxifen-
induced recombination in different brain regions including the hypothalamus and other tissues 
involved in total body metabolism such as muscle or liver (Fig. 3) suggesting that partial 
protection from diet-induced obesity (Fig. 4F) is resulting from the lack of BK channels in 
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adipocytes (Fig. 3). Further, we observed amplified BK expression and currents with 
adipogenic differentiation of both mouse adipocytes from eWAT fat cell precursors as well as 
in the pre-adipocyte 3T3-L1 cell line (Fig. 2K and Suppl. Fig. 4C). Pharmacological blockade 
of BK channels stimulated both growth and lipid incorporation supporting a role of BK 
channels as regulators of cell cycle progression in human pre-adipocytes (7). By assessing 
BK-deficient
 
eWAT and iWAT derived pre-adipocytes in vitro, however, we recognized fat 
depot specific functions for endogenous BK channels potentially involved in control of cell 
growth and lipid accumulation (Fig. 2). Because adiposity is usually induced through 
hypertrophic expansion of existing adipocytes leading to dysfunctional cells, an increase in 
the number of fat cells i.e. hyperplasia is proposed as mechanism that preserves metabolic 
fitness (39). Accordingly, lower levels of the pro-inflammatory cytokine IL-6 (Fig. 6D+E), 
significantly lower body weight (Fig. 4F), and smaller iWAT cell size together support the 
notion that lack of BK leads to the production of more “healthy” adipocytes that may afford 
protection against excessive BW gain thereby maintaining a regular response to the action of 
insulin. Reportedly, adipocytes produce and release IL-6 (40). In obesity the fraction of 
adipose-tissue derived IL-6 may promote a chronic state of low-grade inflammation affecting 
metabolism and development of insulin resistance (41). In comparison to adipoqBK
L1/L2 
mutant mice we find higher IL-6 adipose tissue mRNA (p < 0.05) and non-significantly 
elevated serum levels (p = 0.11) in HFD-fed adipoqBK
+/L2 
control mice, hence, it appears that 
fat cell BK channel activity is positively related to the adipose tissue IL-6 pathway providing 
a link between BK and obesity-related co-morbidities such insulin resistance (Fig. 6D+E and 
H). Interestingly, high plasma and adipose tissue levels of IL-6 were previously reported for 
the ob/ob mouse model (42), suggesting that BK channels may interfere with both, the 
genetic- and dietary-induced causes of adiposity by an IL-6-dependent mode of action. Along 
the same lines, HFD over-nutrition of adipoqBK
L1/L2 
mice revealed lower total fat mass and 
smaller fat cells in iWAT depots. Of note, iWAT cells and depots differed in size and mass 
only in vivo (Fig. 6), whereas in pre-/adipocyte cultures originating from iWAT pads we did 
not detect differences in terms of various adipogenic parameters (Fig. 2). The reason for this 
apparent discrepancy is unclear although several mechanisms could be involved. First, in vivo 
the adipocyte-specific lack of BK channels results in a decrease of the iWAT but not eWAT 
depot fat mass. A “normal” mass of the adipoqBK
L1/L2 
eWAT depot in vivo (Fig. 5A+C) may 
result from direct effects of the BK on the lipid storage and cell growth capacities and both 
parameters were augmented in the respective BK
L1/L1
-derived fat cells in vitro (Fig. 2A-C and 
G+H). In contrast, a lower eWAT depot mass in the global BK knockouts (Fig. 1D) may 
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result from dysregulation of BK-dependent mechanisms in non-adipocytes. Interestingly, our 
observations in HFD-fed adipoqBK
L1/L2
 and adipoqBK
+/L2 
mice imply a small but significant 
increase of approx. 0.3°C in the body’s core temperature in the absence of fat cell BKs (Fig. 
7D), which indicates that these channels are involved in the thermogenic program of adipose 
cells. Presence of UCP1 in iWAT is characteristic of a process known as browning where this 
depot acquires brown adipocyte-like catabolic functions (43), and we find the adipocyte-
specific ablation of BK channels to result in elevated mRNA (data not shown) and protein 
levels of iWAT UCP1 (Fig. 7A-C). Burning of stored fats by expansion or activation of BAT 
or by browning of WAT may result in a metabolically favorable phenotype (44). Accordingly, 
we observed a large fraction of smaller fat cells in iWAT, lower iWAT and total fat depot 
weights as well as an improved glucose homeostasis and insulin sensitivity in HFD-fed 
adipoqBK
L1/L2 
mice (Fig. 7A-C and H-J). 
Clearly, the mechanistic details underlying the lean phenotype of HFD-fed adipoqBK
L1/L2 
mutants require future investigation. In general, it is widely accepted that BK channels are 
activated either by a raise in intracellular Ca
2+
 ([Ca
2+
]i) or by membrane depolarization. 
[Ca
2+
]i dynamics have a multifaceted role for brown adipocyte-like functions and for the 
formation of mature fat laden adipocytes (45-52), however relatively little is known about 
Ca
2+
 signaling in white and brown adipocytes despite its suggested importance (53). Yet, 
efflux of K
+
 via BK in non-excitable cells such as adipocytes may serve as a positive 
regulator for Ca
2+
-entry as well as a number of Ca
2+
-dependent processes, whereas in 
excitable cells BK is usually part of a negative feedback loop limiting influx of Ca
2+
 via 
voltage-dependent Ca
2+
 channels (54). Recently, transient receptor potential vanilloid 4 
(TRPV4) channels have been identified as a major feature of the influx of extracellular Ca
2+
 
into fat cells (55). TRPV4 appears to negatively regulate the thermogenic and 
proinflammatory programs in adipocytes and mice with a TRPV4 ablation were protected 
from diet-induced obesity, hence TRPV4 deficiency results in a phenotype very similar to that 
caused by adipocyte-specific BK ablation. A functional coupling of BK and TRPV4 was 
reported in different systems (56; 57). Although this paper did not examine this link, we 
hypothesize that BK may suppress the acquisition of brown adipocyte-like features in white 
fat cells by an effect on the Ca
2+
-entry and subsequent signaling pathways involving TRPV4 
or other Ca
2+
-permeable members of the large TRP channel protein family (50; 51; 58).  
Finally, BK channels are common targets of various intracellular signaling molecules 
including cyclic guanosine-3´,5´-monophosphate (cGMP) and cyclic adenosine-3´,5´-
monophosphate (cAMP) (59; 60). It is well established that both, cAMP and cGMP pathways, 
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play, among others processes, differential roles in lipolysis, browning of WAT and brown fat 
cell thermogenesis (44; 61), which should allow for complex adjustments of BK function in 
the different fat depots in vivo under patho-/physiological conditions.  
Together, the presented data show that loss of fat cell BK channels supports the browning of 
fat cells to enhance thermogenesis in response to nutritional excess thereby limiting excessive 
weight gain. Targeting fat cells with BK channel inhibitors may thus hold potential to reduce 
pathologic features of excessive weight gain and related disorders. 
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Figure Legends 
 
Figure 1: Global lack of BK channels protects from overwhelming body weight (BW) 
gain and excessive fat accumulation. 
(A) Body weight (BW) increase of BK
+/+
 (blue) and BK
L1/L1
 (red) mice that received a control 
diet (CD) (n=12-14 mice per time-point; open data points) or 45% high-fat diet (HFD) (n=23-
25 mice per time-point, filled data points) for 18 weeks. (B) Body-composition of BK
+/+
 and 
BK
L1/L1
 mice after 18 weeks of dietary feeding was analyzed using the Soxhlet extraction 
method (n=4-7 mice per genotype). Representative images of (C) BK
+/+ 
and BK
L1/L1 
mice after 
18 weeks of CD- or HFD dietary feeding. (D) Fat mass of different white (WAT) and brown 
(BAT) adipose tissue depots of BK
+/+
 and BK
L1/L1
 mice fed either a CD (n=6-9 mice per fat 
depot) or HFD (n=9-16 mice per fat depot). Fat masses were normalized to tibia length 
(Suppl. Fig. 1F) to overcome growth differences between BK
+/+
 and BK
L1/L1
 mice that are not 
related to gain of body adiposity. Relative mRNA-expression of the BK-channel alpha subunit 
in (E) epididymal WAT (eWAT) and (F) subcutaneous inguinal WAT (iWAT) of 10 week 
old BK
+/+ 
and BK
L1/L1
 mice. Glyceraldehyde-3-phosphate dehydrogenase mRNA levels were 
used as a reference to normalize the data, which are presented as means ± SEM. Statistical 
difference between the two genotypes is indicated by * P<0.05, ** P<0.01. Representative 
cryo-sections of (G) eWAT and (H) iWAT stained for the BK alpha-subunit (upper panels) 
using a specific BK channel antibody. As negative control frozen tissue sections without the 
primary BK antibody were processed (lower panels). (G, H) Scale bars represent 200 µm. 
Data were analyzed using the 2-way ANOVA test (A) or Student‘s t-test (B, D-F) and are 
presented as means ± SEM. Statistical difference between the two genotypes is indicated by  
* P<0.05, ** P<0.01, *** P<0.001. Abbreviations used: Epididymal WAT (eWAT); 
interscapular WAT (intWAT); interscapular BAT (intBAT); mesenteric WAT (mesWAT); 
subcutaneous inguinal WAT (iWAT).  
 
Figure 2: Accelerated growth of BK-negative epididymal WAT (eWAT)-derived pre-
adipocytes. 
Representative Oil-red-O (ORO) staining of eWAT-derived pre-adipocytes in (A) high 
magnification and (B) as overviews screen after 14 days of adipogenic differentiation 
revealing higher numbers of mature adipocytes in BK
L1/L1
 in comparison to BK
+/+ 
cells. (C) 
The increased adipogenic potential in BK
L1/L1
 (red) was confirmed by analyzing ORO-
incorporation quantitatively at 518 nm (n=3 independent in vitro assays per genotype). (D, E) 
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Representative ORO staining of inguinal WAT (iWAT)-derived pre-adipocytes after 14 days 
of adipogenic differentiation. Scale bars (A, D) represent 100 µm. (E, F) Based on the ORO-
incorporation assay maturation of iWAT-derived BK
+/+ 
and BK
L1/L1
 pre-adipocytes was not 
different between the genotypes (n=7-8 independent in vitro assays per genotype). (G) 
Representative growth of eWAT-derived pre-adipocytes examined in real-time using an 
impedance-based setup. Lack of BK channels (red) in eWAT-derived pre-adipocytes resulted 
in accelerated growth properties at different cell concentrations tested as compared to wild-
type cells (blue). (H) A pharmacological approach to block the BK channel using 1 µM 
paxilline confirmed the BK-dependent growth capacity of eWAT-derived pre-adipocytes. (I) 
Up-regulation of GLUT4 and BK channel mRNA and (J) protein levels following 
differentiation of eWAT murine pre-adipocytes (pre-adipo) to adipocytes (adipo) (n=3 
independent experiments per group). (K) Pre-adipocyte cells display a small paxilline-
sensitive (1 µM) outward whole-cell BK potassium current determined under physiological 
potassium gradients (n=8 cells) that was significantly increased upon adipogenic 
differentiation for 14 days (n=12 cells). 
 
Figure 3: Spatiotemporal ablation of fat cell BK channels using the adipoqCreERT2
tg/+
 
recombination system. 
Recombination efficiency was determined by a change from red (Cy3-channel) to green 
(FITC-channel) fluorescence using the ROSA26-Tomato
tom/+
 (tom/+) Cre-reporter mouse line. 
(A) Analysis of eWAT and (B) subcutaneous iWAT derived from double-transgenic 
adipoqCreER
tg/+
;
 
ROSA26-Tomato
tom/+
 (tg/+; tom/+) mice with or without tamoxifen (TAM) 
injections in comparison to wildtype age-matched littermate male control mice (+/+; +/+). (C) 
Genomic PCR-analysis of the adipoqCreERT2
tg/+
-mediated recombination of the pre-mutant 
BK gene locus in different tissues. PCR products amplified from the loxP-flanked (L2 allele 
with two loxP sites; two black triangles flanking a closed box), wild type (+ allele; closed 
black box), and knock-out (L1 allele with one loxP site; one black triangle) alleles of 
representative adipoqCreERT2
tg/+
; BK
+/L2
 (adipoqBK
+/L2
) animals. Conversion of the loxP-
flanked L2 allele to the L1 allele was only observed in fat cell depots after injecting tamoxifen 
(+), whereas with saline (-) treatment we did not find evidence for unspecific Cre activity. 
Recombination was analyzed 14 days after the beginning of tamoxifen or saline injections in 
10 weeks old mice. The size of the PCR amplicons were 577 bp, 466 bp and 132 bp for the 
floxed, WT and knockout allele, respectively. Abbreviations used: Pancreas (P); liver (L); 
hypothalamus (H); bulb (B); cerebellum (C); rest of brain (Br); heart (He); skeletal muscle 
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(S); duodenum (D); epididymal white adipose tissue (eWAT); subcutaneous inguinal white 
adipose tissue (iWAT) and brown adipose tissue (BAT); marker (M). (D) Quantitative mRNA 
analysis of the BK mRNA in eWAT and iWAT of TAM-injected adipoqCreER
tg/+
; BK
+/L2
 
control mice (n= 5 for eWAT and iWAT) and age and littermatched adipoqCreER
tg/+
; BK
L1/L2 
tissue-specific mutants n= 7 for eWAT and n=4 iWAT). Analysis of the frequency and 
distribution of the adiponectin-CreERT2-mediated recombination after TAM injections in (E) 
eWAT and (F) iWAT of adipoqCreER
tg/+
; BK
+/L2 
(adipoqBK
+/L2
) and
 
adipoqCreER
tg/+
; 
BK
L1/L2 
(adipoqBK
L1/L2
) mice using a specific BK channel antibody (+anti-BK; upper panels). 
A parallel analysis of serial eWAT and iWAT sections from both genotypes was performed to 
establish the background fluorescence in the absence of BK-specific antibodies (-anti-BK; 
lower panels). Scale bars represent 50 µm. 
 
Figure 4: Reduced BW gain in adipoqBK
L1/L2
 mice receiving a 60% HFD feeding. 
(A) Control diet (CD) feeding protocol. Male adipoqCreER
tg/+
; BK
L1/L2
 (adipoqBK
L1/L2
) and 
adipoqCreER
tg/+
; BK
+/L2
 (adipoqBK
+/L2
) were injected prior to the dietary feeding with 
tamoxifen (TAM) for 5 consecutive days at an age of 8 weeks, which induced a specific and 
efficient ablation of the BK channel in various adipose tissues (see also Fig. 3). Upon 2 weeks 
of adaption to the CD, CD diet feeding was continued or (B) mice revived a HFD for 18 
weeks (prevention study). In an alternative approach additional groups of adipoqBK
L1/L2 
and 
adipoqBK
+/L2 
mice were subjected to the same feeding protocol, but tamoxifen was injected at 
an age of 19 weeks (TAM19) when over-weight has already been established. Food intake of 
adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice were analyzed, using modified metabolic 
cages as described in the methods section either (C) at the beginning (n=4-6 mice per 
genotype) or (D) at the end of the respective dietary feeding (n=3-5 mice per genotype). BW 
development under (E) CD feeding (n=12-20 per genotype/time-point) and (F) HFD feeding 
(n=24-29 mice per genotype/time-point). Difference (∆BW) between the initial BW (at week 
10) and the BW at week 30 in adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice under (G) 
CD and (H) HFD feeding conditions (n=12-15 per genotype for CD, n=24-26 per genotype 
for HFD). (I) Tamoxifen was injected for 5 consecutive days at an age of 19 week when a 
HFD-induced BW gain in adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice was already 
established to test the therapeutic potential of WAT BK inactivation (n=17-22 mice per 
genotype/time-point). The final BW between the two genotypes was significantly different (* 
P<0.05). 
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Figure 5: Reduced fat accumulation and smaller fat depots in adipoqBK
L1/L2 
mice fed a 
60% high-fat diet (HFD).  
Mass of different white (WAT) and brown (BAT) adipose tissue  depots of male 
adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
 (blue) mice examined after 18 weeks of (A) control 
diet (CD) or (B) HFD feeding (n=12-15 per genotype for CD, n=24-26 per genotype for 
HFD). Body-composition of adipoqBK
+/L2 
 and adipoqBK
L1/L2 
at an age of 30 weeks (C) after 
CD and (D) after HFD feeding. Total body fat was extracted using the soxhlet extraction 
method (n=3 per genotype for CD, n=4-7 per genotype for HFD). (E-G) Representative 
pictures of adipoqBK
+/L2
 and adipoqBK
L1/L2 
mice and selected fat depots after 18 weeks on 
CD. (E) View from back, (F) front view with opened abdominal cavity and (G) magnification 
of BAT, eWAT and iWAT. All data were analyzed using the Student‘s t-test and are 
presented as means ± SEM (* P<0.05). (E-G) Scale bars represent 2 cm. Abbreviations used: 
Epididymal WAT (eWAT), interscapular WAT (intWAT), interscapular BAT (intBAT), total 
interscapular adipose tissue  (intAT), mesenteric WAT (mesWAT), subcutaneous inguinal 
WAT (iWAT) and total investigated adipose depots (total). 
 
Figure 6: Fat cell hyperplasia and improved glucose handling in adipoqBK
L1/L2
 mice.  
(A) Average cell size of inguinal WAT (iWAT) of male adipoqBK
+/L2 
 and adipoqBK
L1/L2 
 
mice after 18 weeks of HFD was examined in serial cryo-sections by measuring the 
circumference of cells in central and peripheral regions of the respective depots. (B) 
Classification of average cell sizes (as an indicator of adipose cell number) in adipoqBK
+/L2 
 
and adipoqBK
L1/L2 
 iWAT, prior diet (PD) and after 18 weeks of control diet (CD) or 60% 
high-fat diet (HFD) feeding. (C) Representative cryo-sections of iWAT derived from 
adipoqBK
+/L2 
 (blue) and adipoqBK
L1/L2 
 (red) PD or after either 18 weeks of CD or HFD. 
Scale bars represent 100 µm. Relative (D) mRNA-expression and (E) serum levels of 
interleukin-6 (IL-6) a marker for adipose tissue inflammation and serum levels of (F) 
adiponectin and (G) leptin determined after 18 weeks of CD (open bars) and/or HFD (closed 
bars) feeding in adipoqBK
+/L2 
 (blue) and adipoqBK
L1/L2 
 (red) mice. Blood-glucose (BG) 
levels were monitored before as well as 15, 30, 60 and 120 minutes after i.p. injection of 2 
g/kg glucose (H) after 18 weeks of HFD-feeding and (I) prior the respective diet. (J) Plasma 
insulin levels at baseline (0 min) and during the intraperitoneal glucose-tolerance-test (15 to 
120 min post injection) in adipoqBK
L2/+
 (blue, n=6) and adipoqBK
L1/L2
 (red, n=8) mice after 
18 weeks of HFD-feeding. All data (A, D-J) were examined using the Student‘s t-test and are 
presented as means ± SEM (* P<0.05, ** P<0.01). 
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Figure 7: Increased UCP1 levels and body temperature in HFD-fed adipoqBK
L1/L2 
mice 
(A) UCP1 expression analysis (brown staining in left panels) in frozen tissue sections derived 
from HFD-fed adipoqBK
+/L2
 and adipoqBK
L1/L2
 iWAT. As negative control sections derived 
from the same fat pads were processed in the absence of the primary UCP1 antibody (right 
panels). (B) Representative UCP1immunoblot of iWAT protein lysates derived from HFD-fed 
adipoqBK
+/L2
 and adipoqBK
L1/L2
 mice. Equal loading of the gel was verified by co-detection 
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (C) Quantification of the 
immunoblot data shown in (B). UCP1 protein levels were normalized to the expression of 
GAPDH in adipoqBK
+/L2
 (closed blue bars; n=3) and adipoqBK
L1/L2
 (closed red bars; n=4) 
iWAT samples. (D) Telemetric sensors were used to measure the body core temperature of a 
subset of adipoqBK
+/L2
 and adipoqBK
L1/L2
 mice that received the HFD-feeding. All data (C, 
D) were assessed using the Student‘s t-test and are presented as means ± SEM. * P<0.05, ** 
P<0.01. 
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Abstract 
 
Elevated adipose tissue expression of the Ca
2+
- and voltage-activated K
+
 (BK) channel was 
identified in morbidly obese men carrying a BK gene variant supporting the hypothesis that 
K
+
 channels affect metabolic responses of fat cells to nutrients. To establish the role of 
endogenous BKs for fat cell maturation, storage of excess dietary fat and body-weight (BW) 
gain we studied a gene-targeted mouse model with a global ablation of the BK channel 
(BK
L1/L1
) and adipocyte-specific BK-deficient
 
(adipoqBK
L1/L2
) mice. Global BK deficiency 
afforded protection from high-fat-diet (HFD) induced BW gain and excessive fat 
accumulation. Expansion of white adipose tissue-derived epididymal BK
L1/L1
 pre-adipocytes 
and their differentiation to lipid-filled mature adipocytes in vitro, however, were improved. 
Moreover, BW gain and total fat masses of usually super-obese ob/ob mice were significantly 
attenuated in the absence of BK together supporting a central or peripheral role for BKs in the 
regulatory system that controls adipose tissue and weight. Accordingly, HFD-fed 
adipoqBK
L1/L2
 mutants presented with a reduced total BW and overall body fat mass, smaller 
adipocytes and reduced leptin levels. Protection from pathologic weight gain in the absence of 
adipocyte BKs was beneficial for glucose handling and related to an increase in body core 
temperature due to higher levels of uncoupling protein 1 as well as low abundance of the pro-
inflammatory interleukin-6 as a common risk factor for diabetes and metabolic abnormalities. 
This suggests that adipocyte BK activity is at least partially responsible for excessive BW 
gain under high-caloric conditions suggesting BK channels as promising drug targets for 
pharmacotherapy of metabolic disorders and obesity.  
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Introduction 
Obesity is caused by high calorie intake, typically derived from dietary fats or sugars. Over 
time, an imbalance between nutrient consumption and burning of calories leads to a massive 
increase in fat mass, which among other factors is a major cause of insulin resistance and 
diabetes (1; 2). Additionally, genetic mutations may cause excessive lipid accumulation and 
thereby a morbid gain in body weight (BW) emphasizing the multifactorial etiology of 
chronic excessive weight gain (3; 4). It has become increasingly clear that a variety of K
+
 ion 
channels i.e. K
+
 channels expressed within the brain and in the periphery, possibly by 
complex effects on appetite and satiety, energy expenditure, glucose balance and/or fat cell 
function, are involved in the patho-physiology of obesity and related disorders (5). 
Accordingly, a genome wide association study recently identified the human KCNMA1 gene, 
encoding for the pore forming subunit of the large-conductance Ca
2+
-activated K
+
 channel 
(BK), as a novel susceptibility locus for obesity (6). BK channel mRNA levels in variant-
carriers were significantly increased in white adipose tissue (WAT) and adipose tissue-
derived cells, suggesting a pathogenic role for fat cell BK on metabolism. Others reported 
electrophysiological evidence for BK channels in human pre-adipocytes and BK knock-down, 
or its pharmacological inhibition, further revealed a possible link between channel activity 
and proliferative capacity of these cells (7), whereas Ca
2+
-activated K
+
 channels of the IK 
type seem to be dominant in the widely-studied murine pre-adipocyte model 3T3-L1 (8). 
Because both peripheral and central organs, involved in the control of metabolism, express 
BK it is, however, difficult to estimate the impact of pre-adipocyte BKs on fat cell formation 
and adiposity in vivo. For example, a direct modulation of BK by fatty acids and their 
metabolites seems to provide a possible link between lipid-mediated effects on the channel 
and altered vascular functions in hypertriglyceridemia secondary to obesity (9-13). Previous 
analyses of global BK knock-out mice imply that both glucose-induced insulin secretion and 
endocrine output from the hypothalamic-pituitary-adrenal (HPA) axis, require endogenous 
BK channels (14; 15). However, it has not been determined whether these dysregulations in 
β-cell or HPA function caused metabolic abnormalities in vivo (16). Moreover, several studies 
find BK promote inhibitory effects of leptin signaling, via PI3-kinase in hippocampal neurons 
(17) and in mouse chromaffin cells (18), suggesting that neuronal circuits controlling appetite 
and energy expenditure may also depend on functional BK. A malfunction of neuronal 
circuits has been widely appreciated as causing excessive fat storage (19) and a number of 
studies, indeed, found evidence for BK in brainstem, different hypothalamic nuclei, parts of 
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the cortex and limbic system, hence in brain regions that are implicated in the central control 
of food intake, appetite and energy expenditure (20; 21).  
The recent discovery of functional channels with properties similar to BK in fat cell 
progenitors (7) together with the link between high fat cell BK mRNA expression levels and 
morbid adiposity (6) suggest that BK activity in the adipose tissue plays, yet to be discovered, 
physiologically and pathophysiologically important roles for weight control. In order to 
establish endogenous BK channels as potential modulators of fat deposition and excessive 
weight gain we herein assessed the susceptibility of global and adipocyte-specific BK mouse 
mutants towards genetic- and dietary-induced causes of adiposity. Our approach to validate 
BK as a novel player in the response to obesogenic factors in vivo should also direct future 
studies on the pharmacotherapy of adiposity and related disorders.  
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Research design and methods  
Animals and diets. All animal experiments were performed with permission of the local 
authorities and conducted in accordance with the German legislation on the protection of 
animals. Animals were housed in cages under controlled environmental conditions with 
temperatures maintained between 21-24°C, humidity at 45-55% and 12h light-dark-cycle.  
Global BK channel deficient mice (genotype: BK
L1/L1
), heterozygous (genotype: BK
L1/+
) and 
wildtype littermates (genotype: BK
+/+
) on a C57BL/6N background were generated and 
maintained at the Institute of Pharmacy, Department of Pharmacology, Toxicology and 
Clinical Pharmacy, University of Tübingen as described previously (22). To produce BK
L1/L1
 
mice which are also unable to produce functional leptin (genotype: BK
L1/L1
; B6.V-Lep
ob/ob
 
(BK
L1/L1
; ob/ob)) BK
L1/+ 
animals were crossed to mice carrying a heterozygous mutation of the 
leptin-gene B6.V-Lep
+/ob
 J (ob/+) obtained from Charles River, Germany. Intercrossing of 
double-heterozygous animals (genotype: BK
L1/+
; B6.V-Lep
ob/+
 (BK
L1/+
; ob/+)) produced 
homozygous obese BK
L1/L1
; ob/ob, obese BK
+/+
 (genotype: BK
+/+
; B6.V-Lep
ob/ob
 (BK
+/+
; 
ob/ob)), lean BK
L1/L1
 (BK
L1/L1
; B6.V-Lep
+/+ 
(BK
L1/ L1
; +/+)) and lean BK
+/+ 
(BK
+/+
; B6.V-
Lep
+/+  
(BK
+/+
; +/+)) offspring from the same litters. In order to obtain tissue-specific mutants 
lacking BK in various adipocyte populations heterozygous BK mice (BK
L1/+
) on C57BL6 
background, carrying a tamoxifen inducible adipose tissue-specific Cre recombinase 
(genotype: adiponectin-CreERT2
tg/+
) under control of the adiponectin promoter (23), were 
first mated to homozygous floxed BK animals (genotype: BK
L2/L2
). Adipocyte-specific 
controls (genotype: adiponectin-CreERT2
tg/+
; BK
+/L2
 (adipoqBK
+/L2
)) and pre-mutant BK 
animals (genotype: adiponectin-CreERT2
tg/+
; BK
L1/L2 
(adipoqBK
L1/L2
)) derived from this 
breeding were injected with tamoxifen (1 mg/d) for 5 consecutive days to induce Cre-
mediated recombination at an age of 8 weeks (Fig. 3 and Fig. 4C-H) or 19 weeks (Fig. 4I).  
The specificity and efficiency of the adiponectin-CreERT2-derived recombination 
 
was 
supported by studying double fluorescent ROSA26-Tomato reporter mice (genotype: 
ROSA26
mTomato/mEGFP
 ((tom/+)) obtained from Charles River, Germany (24) expressing the 
adipoqCreERT2 transgene (genotype: adiponectin-CreERT2
tg/+
; ROSA26-Tomatotom/+; 
(adipoq
tg/+
; tom/+). Double-transgenic animals were either injected with tamoxifen for 5 days 
as described to induce recombination of the reporter allele i.e. a switch from cell membrane-
localized red fluorescence to green fluorescence proteins or received solvent. Genotyping was 
performed using specific primers to identify the Cre transgene (23), the single nucleotide 
mutation in the leptin gene (according to a protocol for Stock Number: 000632 by The 
Jackson Laboratory) and the L1, L2 and wild-type alleles of the BK on DNA samples 
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obtained either from different fat depots, control tissue or tail-tip biopsies from mice that were 
left untreated or received tamoxifen as described previously (22).  
Prior to the different research diets, all experimental mice received tap water and a 
commercial chow obtained from Altromin, Germany ad libitum. Dietary feeding trials were 
performed in male mice that were allowed to adapt to a defined control-diet (CD) formulation 
containing 10% of calories due to fat for two weeks prior the long-term feeding experiments. 
With 10 weeks of age experimental mice either received a high-fat-diet (HFD) containing 
45% or 60% of calories due to fat or were continued to feed the CD for another 18 weeks. 
Progressive body weight gain in the monogenetic model of obesity was monitored between 4 
and 24 weeks of age on normal chow diet. 
 
Food intake and body core temperature measurements 
The core body temperature and the locomotor activity were measured by using a telemetry 
setup (ETA-F10 with the two-lead ECG transmitters of the implant removed because they 
were not required for monitoring the activity and temperature; Data Sciences, Inc.). The 
surgical procedure was described previously (25). In brief, anesthesia was induced by a 4% 
isoflurane in oxygen inhalation and was then maintained with 1-2% isoflurane. By aseptic 
technique the implants were placed in the peritoneal cavity and the skin was closed with a 5/0 
surgical silk. During recovery, mice were placed on a warming pad before they were returned 
to their home cages for at least 3 days before recordings were started. Activity and body core 
temperature were assessed continuously for 96 hours in experimental mice that had received 
the HFD diet for 18 weeks. 
Food intake was measured using a non-automated and modified metabolic cage setup. To 
reduce the environmental stress in the feeding chamber of the metabolic cage mice housed 
individually were placed on paper bedding that was renewed daily. After two days of 
acclimatization food consumption was assessed for 4 days using an analytic balance. Foot 
pellets were replaced every 24 hours. The amount of food consumed by each individual 
mouse was determined by calculating the weight differences between the initial weight of the 
pellets and the final pellet weights 24 hours later. Food pieces dropped by the animals on the 
paper bedding were thoroughly collected and included in the final weight determination. Food 
intake was assessed in a subset of experimental mice prior the dietary feeding at an age of 10 
weeks or after the CD or HFD feeding protocols. 
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Growth and maturation of pre-adipocytes in vitro. Pre-adipocytes derived from iWAT or 
eWAT of 10 week old BK
+/+
 and BK
L1/L1
 mice were isolated by an established collagenase 
liberation protocol (26). Upon 50 min of digestion in Collagenase type I/HEPES buffer at 
37°C, 2x10
4 
or 5x10
4 
cells/cm² from iWAT or eWAT were plated in DMEM-Ham’s F12 with 
5% FCS, respectively. At 90-100% cell confluency maturation was induced by addition of 
induction medium containing insulin (170 nM), dexamethasone (1 µM), 
isobutylmethylxanthin (500 µM) and indomethacine (30 µM) to eWAT cultures. 
Differentiation of iWAT pre-adipocytes was stimulated by adding rosiglitazone (2.5 µM) and 
triiodothyronine (1 nM) to the eWAT induction medium. After 48h of induction the medium 
was exchanged by insulin (170 nM) containing medium in DMEM-Ham’sF12 with 10% FCS 
for another 48h, followed by maintenance medium (DMEM-Ham’sF12 with 10% FCS). 
Maintenance medium was changed every second day until cells were mature, usually 14 to 16 
days after plating. Triglyceride-incorporation was detected by Oil-red-O (ORO) staining. 
ORO-content was quantified by photometry using the Implen-system at 518 nm. Digital 
images of the maturation process were acquired using AxioVision software version 4.8 (Carl 
Zeiss, Jena, Germany). Cell-growth and proliferation assays were analyzed in real-time using 
the xCELLigence impedance setup (OMNI life science, Bremen, Germany) during the first 60 
hours upon plating in DMEM-Ham’sF12 with 5% FCS medium. Data was acquired and 
analyzed using the RTCA software version 1.2.1 (ACEA Biosciencis Inc.). 
 
Electrophysiological recordings. The conventional whole-cell mode of patch clamp 
electrophysiology was used to analyse BK currents in undifferentiated and differentiated 3T3-
L1 cells as well as from pre-adipocytes and induced matured adipocytes prepared from 
primary cultures of mouse eWAT. The pipette solution contained 140 mM KCl, 10 mM 
HEPES, 30 mM Glucose, 1 mM BAPTA, 2 mM MgCl and free calcium buffered to 0.5µM at 
pH 7.2. The standard bath (extracellular) solution contained (in mM): 140 mM NaCl  5 mM 
KCL  10 mM HEPES, 20 mM Glucose, 2 mM MgCl and 1 mM CaCl and pH was adjusted to 
7.4. Electrophysiological recordings were performed at room temperature (18-22°C) using 
pCLAMP 9 (Molecular Devices) with a sampling rate of 10 kHz and filtered at 2 kHz. Patch 
pipettes were fabricated from borosilicate glass (Garner) with resistances between 2-3 MΩ. 
Drugs were applied to cells using a gravity perfusion system with a flow rate of 1-2 ml/min to 
minimise flow-induced artefacts. For analysis of BK currents, the BK channel specific 
blocker paxilline (1µM) was applied and the paxilline-sensitive outward current analysed at 
the membrane voltages indicated in the respective figure legends. 
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Adipose tissue histology. For histological examination tissues were fixed in 4% 
paraformaldehyde for 1.5 hours directly after harvesting and were then embedded in NEG 
50™ (Richard-Allan Scientific, Thermo Scientific) for sectioning following sucrose-gradient 
cryoprotection. Serial 14-µm cryo-sections of different WAT depots were prepared using a 
HM 560 cryostat (Thermo Scientific, Waltham, USA) and stored at -80°C until further 
processing. To determine the size of the fat cells prior to and after different diets their 
perimeter was determined in digital images of the iWAT depot using the AxioVision software 
package version 4.8 (Carl Zeiss, Oberkochen, Germany). The uncoupling protein 1 (UCP1) 
expression pattern was compared between iWAT cryo-sections obtained from HFD-fed 
adipoqBK
L1/L2 
and adipoqBK
+/L2 
mice using a commercial antibody (Santa Cruz, Dallas, USA) 
(dilution 1:400). BK immunodetection was performed in iWAT and eWAT sections derived 
from 10-week old global and adipocyte-specific BK mutants and control litters using a 
primary antibody, specific for the BK channel alpha subunit (dilution 1:1000) and hormone-
sensitive lipase (HSL; dilution 1:400) according to a previously published protocol (27). In 
brief, antigen-antibody-complexes were detected by a fluorescense-labeled secondary 
antibody (AlexaFluor®568; anti-rabbit) (dilution 1:500) using the AxioCam MR system (Carl 
Zeiss, Oberkochen, Germany) or by appropriate secondary antibodies conjugated to 
horseradish peroxidase (dilution 1:500). 
 
Adipose tissue mass and total body composition. To determine total fat mass and individual 
mass of different depots fat pads were dissected unfixed upon dietary-feeding then weighed, 
immediately immersed in liquid nitrogen and finally stored at -80°C for further analysis. For 
total body-composition analysis total body weight was determined prior and after drying the 
corpse for 24 hours at 85°C. Water content was calculated as difference between dry and total 
weight. Fat-content was determined in dried corpses using the Soxhlet procedure according to 
a previously published protocol (28). 
 
Blood parameters and glucose tolerance test. Blood was collected from mice prior to or 
after dietary feeding. Leptin, IL-6 and adiponectin levels were measured in serum samples 
with mouse immunoassay kits (Merck Millipore, Darmstadt, Germany) according to 
manufacturer’s instructions. Blood glucose was determined using the GlucoCheck advance 
system (TREND Pharma GmbH, Saalfeld/Saale, Germany) immediately before i.p. glucose 
challenge (2 g/kg of body-weight) as well as 15, 30, 60 and 120 min after the injection in 
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over-night fasted mice. At each time additional blood (25 µl) was collected via the tail vein 
for subsequent insulin determination. Plasma-Insulin was measured using the Ultra Sensitive 
mouse Insulin ELISA (Mercodia, Uppsala Sweden), according to manufacturer’s instructions. 
 
mRNA expression analysis. Total mRNA was extracted from WAT samples by a 
guanidineisothiocyanat-phenol-chloroform extraction protocol using PegGold RNA Pure 
(Peqlab Biotechnologie, Erlangen, Germany) according to the manufacturer’s instructions. 
Following DNase treatment for 30 min to remove traces of genomic DNA, RNA samples 
were quantified and 0.5 µg RNA were used to generate cDNA using the ISRIPT cDNA 
synthesis kit (Bio-Rad, Hercules, USA). Quantitative real-time PCR was performed in 
triplicates using the comparative 2
−∆C(t)
 method, with C(t) indicating the cycle number at 
which the signal of the PCR product crosses the threshold, set within the exponential phase of 
the detected fluorescence signal. BK- and IL-6-levels were normalized to β-actin to determine 
their relative quantitates. The respective primer sequences designated were: BK forward: 5’- 
GAC GCC TCT TCA TGG TCT TC -3’, BK reverse: 5’-TAG GAG CCC CCG TAT TTC 
TT-3’; IL-6 forward: 5’- CTT CAA CCA AGA GGT AAA AG -3’, IL-6 reverse: 5’-CCA 
GCT TAT CTG TTA GGA GAG -3’. For extraction of total mRNA from 3T3-L1 cells or pre-
adipocytes and differentiated adipocytes in culture the Roche High pure mRNA extraction kit 
was used according to the manufacturer’s instructions following shearing of cells in lysis 
buffer using a 25G needle. Following DNase treatment as above 0.25 µg RNA were used to 
generate cDNA using the Roche Transcriptor Hi-Fidelity cDNA synthesis kit with random 
hexamers and oligo-dT used at a 2:1 ratio. qRT-PCR was performed using the comparative 
2
−∆∆C(t)
 method as above with mRNA levels normalized to Ipo8. The respective primers were: 
BK forward: 5’-GTC TCC AAT GAA ATG TAC ACA GAA TAT C; BK reverse primer: 5’-
CTA TCA TCA GGA GCT TAA GCT TCA CA; GLUT4 using the Quantitect Assay 
(Mm_Slc2a4_2_SG) and Ipo8 using Quantitect assay (Mm_Ipo8_2_SG) from Qiagen.  
 
3T3-L1 culture and differentiation. Undifferentiated (UD) 3T3-L1 fibroblasts were 
maintained in Dulbecco’s modified Eagle’s Medium (DMEM) containing 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin at 37
o
C at 10% CO2 and passaged every 4 days 
after reaching 60-80% confluency. Differentiation was initiated in confluent monolayers in 
DMEM/FBS containing 1µg/ml insulin, 0.25µM dexamethasone, 1µM troglitazone and 
500µM IBMX for 3 days followed DMEM/FBS containing 1µg/ml insulin and 1µM 
troglitazone. After 3 days cell medium was replaced with DMEM/FBS and medium refreshed 
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every 3 days until differentiated cells (DF) were analysed (typically 10-14 days after initiation 
of differentiation). 
 
Immunoblot analysis of iWAT and 3T3-L1 derived protein lysates. Inguinal WAT was 
dissected and processed as described in order to generate total protein lysates for subsequent 
immunoblot analyses (27). Total protein was obtained from undifferentiated and differentiated 
3T3-L1 fibroblasts. Separation of the proteins by molecular weight was done by gel 
electrophoresis using 12% SDS gels. For immunodetection primary UCP1 (Santa Cruz, 
Dallas, USA) (dilution 1:1000), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
dilution 1:1000) (Cell Signaling), glucose transporter type 4 (GLUT4, 1:1000) (generous Gift 
from Gwyn Gould, Glasgow, UK), BK (1:1000) (NeuroMab, UC Davis, USA) and β-actin 
(1:500) (Sigma-Aldrich, St. Louis, USA) antibodies were used. 
 
Statistical analysis. Statistical analysis was performed on experimental data using a two-
tailed student’s t-test for paired or unpaired comparison or ANOVA with post-hoc Dunnett’s 
test for multiple comparisons where appropriate. All data are presented as mean ± SEM. For 
all tests, p-values less than 0.05 were considered as significant: P<0.05 (*), P<0.01 (**), 
P<0.001 (***). 
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Results 
Body weight (BW) gain was investigated in global BK-deficient (BK
L1/L1
) and age- and litter-
matched male wild-type mice (BK
+/+
) (Fig. 1A) receiving either a purified low-fat control 
(CD) or a high-fat diet (HFD). Prior to the different diets we observed a small but highly 
significant (P<0.001) difference in the BWs between the two genotypes as previously 
reported (29; 30). Starting with 5 weeks of HFD feeding, however, a substantial weight gain 
in male BK
+/+ 
mice became apparent resulting in a total BW gain of 16.44 ± 0.83 g for BK
+/+ 
mice at the end of a 18 weeks HFD feeding protocol (Suppl. Fig. 1A), whereas BK
L1/L1
 
mutants gained 8.37 ± 0.45 g in the same observation period. Importantly, the differences in 
BW gain of BK
L1/L1 
mutants were about than 10 % for CD (33.34 ± 2.38%) and HFD (44.26 ± 
2.68%) fed groups, whereas the respective difference in the diet induced BW gain for BK
+/+ 
mice was 27.76% (Suppl. Fig. 1B). Neither daily food intake of BK
+/+ 
and BK
L1/L1 
mice under 
CD- or HFD-fed conditions (Suppl. Fig. 1C) nor the activity or body-temperature of the 
animals differed significantly (Suppl. Fig. 1D-E) under HFD suggesting that the lean 
phenotype of the BK
L1/L1
 mice was, at least not primarily, due to abnormal hyperactivity or 
dysfunctions in central control of peripheral circuits regulating food intake and reward 
behaviors. Body-composition revealed that the HFD feeding did not affect wet body mass and 
carcass dry mass but rather stimulated a substantial increase in the total body fat mass in 
BK
+/+ 
mice, whereas the respective body-composition of CD- and HFD-fed BK
L1/L1 
did not 
differ (Fig. 1B) supporting the notion that the genotype-specific differences in BW upon CD 
and HFD feeding (Fig. 1A) are largely due to reduced accumulation of fat in the absence of 
BK. Less total body fat mass of CD- and HFD-fed BK
L1/L1 
mice
 
were accompanied by a small 
but significant shift to lower dry mass values and reduced tibial length (TL) (Suppl. Fig. 1F) 
both confirmatory for the lower overall body size in the global absence of BK channels (Fig. 
1C). Analyses of fat mass-normalized to TL revealed significant weight differences for 
various white adipose tissue (WAT) depots as well as the interscapular brown adipose tissue 
(BAT) indicating that the lean phenotype of the BK
L1/L1 
mice was related to a decrease in 
multiple adipocyte tissue cell populations (Fig. 1D). So far, the data suggest that high-caloric 
nutrition-induced BW gain requires functional BK channels. Additionally, the reduced TL, in 
the global BK knock-outs is in accordance with previous reports collectively implying a mild 
growth defect that may contribute, at least partly, to the differences observed between BK
+/+ 
and BK
L1/L1
 BW during dietary feeding (30). We next tested whether BK plays a role for the 
excessive fat accumulation in the monogenic ob/ob model of morbid obesity. BW gain 
(Suppl. Fig. 2A), body-composition (Suppl. Fig. 2B+C) and individual weights of different fat 
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depots (Suppl. Fig. 2D) were studied in BK-negative ob/ob double-mutants and age- and 
litter-matched ob/ob controls. In line with the HFD-fed BK
+/+
 and BK
L1/L1
 mice we find that 
key parameters of the progressively developing super-obese phenotype, including body 
weight, body-composition and fat depot masses are attenuated in the absence of BK (Suppl. 
Fig. 2A-D). In contrast, differences in BW gain between lean control mice in the absence 
(∆16.83 ± 0.55 g) and presence (∆15.73 ± 0.55 g) of BK were not significant (p = 0.17). 
Protection against overwhelming BW gain in the BK-deficient ob/ob model was related to a 
consistent effect on total fat masses and non-fat components of the body (Suppl. Fig. 2B). 
Indeed, a lower initial as well final BW of BK-negative lean and ob/ob double-mutant mice 
(Suppl. Fig. 2A) as well as differences in the mean TL (Suppl. Fig. 2E) suggest that BK plays 
a role for normal growth development (Suppl. Fig. 2) and morbid obesity resulting from leptin 
deficiency. 
Based on previous reports on the role of K
+
-channels in adipocytes (6; 7) and our consistent 
observation of lower fat masses of multiple fat depots (Fig. 1D and Suppl. Fig. 2D) we 
considered that the protection from overwhelming weight gain was stemming from the 
adipocyte itself. To address this possibility, we first assessed the BK mRNA and protein 
expression in inguinal and epididymal white adipose tissue (iWAT and eWAT, respectively). 
Fat pads were studied using primer pairs allowing for specific detection and quantification of 
BK mRNA (Fig. 1E+F). As compared to the internal reference BK levels in BK
+/+ 
iWAT and 
eWAT depots were low but reliable amplification was accomplished in all samples tested. 
Importantly, signal traces detected in the respective fat depots derived from BK
L1/L1 
mice were 
well in the range of non-specific PCR product formation in the absence of reverse 
transcriptase (Suppl. Fig. 3A+B). Because adipose tissue is heterogeneous, composed of fat- 
and non-fat cells, we next examined the cellular distribution of BK channel protein in frozen 
adipose tissue sections obtained from 10 week old BK
+/+ 
and BK
L1/L1 
mice. These analyses 
revealed evidence for BK in unilocular BK
+/+ 
cells, characteristic of white adipocytes, 
whereas BK
L1/L1
 iWAT and eWAT remained BK-negative (Fig. 1G+H). Importantly, our 
specific BK antibodies and an antibody for the white fat cell marker hormone-sensitive lipase 
(HSL) marked the same cells in BK
+/+ 
eWAT (Suppl. Fig. 3C) supporting the notion that 
mature adipocytes express BK channels.  
 
To explore the functional attributes of endogenous BK channels in adipocytes we adopted a 
previously established protocol of primary culture and differentiation of murine adipocyte 
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precursor cells (26). Adipocyte differentiation was induced at 90-100% confluence of BK
+/+ 
and BK
L1/L1 
precursor cells derived either from eWAT and iWAT depots. Oil-red-O (ORO) 
incorporation into lipid droplets revealed strong accumulation of lipid-filled adipocyte-like 
cells under adipogenic maintenance conditions in cell cultures derived from both BK-negative 
and BK
+/+ 
eWAT (Fig. 2A-C) and iWAT (Fig. 2D-F). In iWAT-derived cultures we did not 
observe differences in the adipogenic differentiation among genotypes (Fig. 2D-F), whereas 
the amount of ORO incorporation was significantly higher in BK
L1/L1
 than BK
+/+ 
cultures 
established from
 
eWAT (Fig. 2A-C) suggesting a depot-specific role for BK on in vitro lipid-
storage. Moreover, genetic and pharmacological blockade of BK channels enhanced the 
growth of eWAT-derived pre-adipocytes (Fig. 2G+H).  
To further validate differentiated adipocytes from eWAT express functional BK channels, we 
assayed BK mRNA, protein and ionic currents in the differentiated cultures. BK channel, as 
well as GLUT4 transporter, mRNA and protein were strongly upregulated in differentiated 
cells compared to precursor cells (Fig. 2I+J). Importantly, outward potassium currents, 
sensitive to the specific BK channel blocker paxilline (1 µM), were significantly upregulated 
in differentiated adipocytes (Fig. 2K). An increase in BK channel mRNA, protein and 
currents were also observed in the established 3T3-L1 pre-adipocyte cell model following 
induction of differentiation (Suppl. Fig. 4A-C). In addition, inhibition of BK channels with 
paxilline increased the growth of 3T3-L1 pre-adipocytes and the amount of ORO 
incorporation into lipid droplets (Suppl. Fig. 4D+E). Taken together, these data suggest that 
fat cell BK channels control pre-adipocyte expansion and adipogenic conversion of pre-
adipocytes in an adipocyte depot specific manner.  
Because homeostasis of mature adipocyte and adipocyte differentiation in vivo are distinct 
from the above studied in vitro models, we next studied the lean phenotype by generating an 
adipocyte-specific BK knock-out mouse model (adipoqBK
L1/L2
). In a first series of 
experiments we confirmed the tissue-specific recombination efficacy of the recently 
established adiponectin promotor-driven tamoxifen-inducible CreERT2 mouse model (23) 
using a two-color fluorescent Cre reporter system (24). Prior to Cre-mediated excision we 
observed ubiquitous expression of a cell membrane-targeted red fluorescent Tomato (mT) in 
eWAT, iWAT and all other tissues studied suggesting that the ROSA
mT/mG
 mouse is indeed a 
global Cre reporter model (Fig. 3A+B and data not shown). Tamoxifen induced Cre-mediated 
excision of the floxed mT was leading to an almost complete switch to green fluorescent 
protein (mG) expression in eWAT and iWAT fat cells, whereas changes in mT labelling were 
not observed in various other organs such as brain, skeletal muscle, and liver (data not 
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shown). High efficiency and specificity of the adiponectin-CreERT2 approach was further 
confirmed by a BK specific primer set designed to identify the three different BK alleles i.e. 
wild-type (+), floxed (L2) and knock-out (L1) within one sample. In line with the Cre-reporter 
assay (Fig. 3A+B) PCR products indicative of a recombination event were only observed in 
white and brown adipocyte tissues of adiponectin-CreERT2 transgenic BK
+/L2
 mice 
(adipoqBK
+/L2
), whereas analysis of multiple other cell types and organ systems did not reveal 
significant Cre activity regardless of whether tamoxifen was applied or not (Fig. 3C). As 
compared to adipoqBK
+/L2 
controls,
 
eWAT and iWAT
 
BK mRNA expression levels were 
reduced in tissue-specific adipoqBK
L1/L2 
mutants upon tamoxifen application (Fig. 3D). 
Accordingly, adiponectin-CreERT2 activation by tamoxifen resulted in a nearly complete 
ablation of the BK protein in the different WAT tissues (Fig. 3E+F). Hence, the adipocyte-
specific knock-out model of BK should allow us to test the role of fat cell BK channels for 
BW gain under CD- and HFD-feeding conditions in the absence of changes in satiety or 
adiposity signals arising from endocrine or neuronal circuits potentially involving 
hypothalamic BK channels among others. To induce site-specific recombination of the L2 BK 
gene locus, adipoqBK
L1/L2 
mice as well as adipoqBK
+/L2 
control age- and littermates were 
subjected to the tamoxifen injection 2 weeks prior to the experimental diets i.e. a CD or a 
HFD with 60% of its calories derived from fat (Fig. 4A+B). Consistent with our previous 
findings in the global BK
L1/L1 
model (Suppl. Fig. 1C), the tissue-specific ablation of BK did 
not affect the amount of CD or HFD food consumed by the animals at the start or end of the 
feeding experiment (Fig.4C+D). Starting BWs and BW gain in the CD group were not 
different between adipoqBK
+/L2 
and adipoqBK
L1/L2 
mice (Fig. 4E+G), whereas lack of 
adipocyte BK channels afforded partial protection against HFD-induced gain in BW (Fig. 
4F+H), an effect that reached the significance level after 4 weeks of HFD-feeding and was 
maintained until the mice reached their final BWs (Fig. 4F) indicative for a lower 
susceptibility of adipoqBK
L1/L2 
mutant mice towards high caloric challenges. We next tested 
whether excess BW gain is also affected by fat cell BK in mice which have already 
established significant weight gain. To test this, tamoxifen treatment was commenced at an 
age of 19 weeks when the adipoqBK
+/L2 
control and adipoqBK
L1/L2 
pre- mutants had reached a 
BW of 32.35 ± 1.05 g and 31.91 ± 0.89 g, respectively. Total BW gain was not different 
between age-and litter-matched adipoqBK
+/L2
 and adipoqBK
L1/L2 
mice prior to the tamoxifen 
treatment (t10-19 8.18 ± 1.00 g for adipoqBK
+/L2 
and t10-19 7.71 ± 0.76 g for adipoqBK
L1/L2 
(P = 
0.7)), whereas upon five repetitive tamoxifen injections the extent of the weight gain showed 
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a clear tendency towards lower values in adipoqBK
L1/L2 
 mice (Fig. 4I) (t20-30 5.33 ± 0.56 g for 
adipoqBK
L1/L2
  and t20-30 7.40 ± 1.03 g for adipoqBK
+/L2 
(P<0.06))  
In depth analyses of the individual fat depots (Fig. 5A+G) and the total fat mass (Fig. 5B) did 
not reveal statistical weight differences between adipoqBK
+/L2 
and adipoqBK
L1/L2 
fed a CD 
diet. HFD feeding, however, confirmed protection from excessive fat storage in adipoBK
L1/L2 
mice. Interestingly, lack of adipocyte BK was associated with lower total fat masses and 
lower masses of various fat depots (Fig. 5C-G). Because fat mass is determined by both 
adipocyte number and size we next studied fat storage at the cellular level. Inguinal WAT cell 
size was calculated by assessing the cell perimeters in different cryo-sectional areas obtained 
from adipoqBK
+/L2 
and adipoqBK
L1/L2 
mice. Prior to the different diets i.e. at an age of 10 
weeks genotype-specific differences in fat cell size were not detectable in different areas of 
the iWAT sections (Fig. 6A+C). As compared to adipoqBK
+/L2
 fat cells,
 
BK-deficient 
adipocytes were smaller upon CD and HFD feeding (Fig. 6A+C). Because enlarged, 
hypertrophic fat cells in the adipose depot relate to obesity, inflammation and insulin 
resistance we next tested whether the observed changes in adipocyte morphology (Fig. 6A-C) 
associates with a more proinflammatory state. Indeed, we find reduced IL-6 mRNA 
expression in iWAT of HFD-fed adipoqBK
L1/L2 
mice and tendentially lower serum IL-6 levels 
(Fig. 6E; p = 0.11). Moreover, HFD-fed adipoqBK
L1/L2 
mice exhibited lower serum leptin 
levels as a marker of body-mass (Fig. 6F), whereas adiponectin concentrations were not 
different between diets or genotypes (Fig. 6G). In accordance with the markers of 
inflammation, low adipose tissue mass and fat cell hypertrophy, adipoqBK
L1/L2 
mice showed
 
an improved glucose clearance (Fig. 6H) with lower insulin levels (Fig. 6J) upon intra-
peritoneal glucose challenge after HFD-feeding, whereas lack of adipocyte BK did not affect 
glucose handling prior to the feeding protocol (Fig. 6I). Change in cellularity of the iWAT 
may also be taken as an indicator for accelerated browning to promote energy expenditure 
which will counter obesity and its metabolic consequences. Lack of fat cell BK resulted in 
strong induction of the uncoupling protein 1 (UCP1) (Fig. 7A+C) as a hallmark of uncoupled 
respiration and heat production by brown or brown adipocyte-like fat cells. Higher levels of 
UCP1 protein under HFD-fed conditions were also reflected by a significant increase in core 
body temperature during the night (Fig. 7D), whereas during the day, while the mice were 
sleeping, body temperatures of adipoqBK
L1/L2
 and adipoqBK
+/L2
 mice were lower suggesting a 
reduced burning of stored fats with no apparent differences between the two genotypes (Fig. 
7D). 
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In summary, adipocyte BKs promote fat cell size and fat pad mass in vivo. Adipocyte tissue 
growth in the presence of endogenous BK channels was related to a noninfectious activation 
of adipose tissue inflammation and metabolically unfavourable effects on fat cell functions, 
which together may result in insulin resistance and amplified HFD-induced adiposity. 
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Discussion 
By combined analysis of different BK channel mutant mouse lines we have uncovered a novel 
function for adipocyte BKs in fat cell biology and metabolism under different nutritional 
conditions. We find resistance to HFD-induced BW gain, lower total fat mass and thereby 
improved glucose handling upon ablation of endogenous BK channels in adipose depots in 
different parts of the body. These data imply that the development of obesity caused by 
nutrient excess is promoted by the BK channel (Fig. 4). Accordingly, a previously identified 
BK gene variant was associated with elevated levels of fat cell BK mRNA in morbidly obese 
human subjects suggesting a causal relationship between the amount of adipocyte BKs and 
weight gain (6). To the best of our knowledge, BK levels in other organ systems of the 
affected patients have not been assessed; therefore, it remains unclear if the obesogenic 
effects attributed to amplified BK expression resulted exclusively from an effect on adipocyte 
cell function or whether BK channels present in non-adipocyte cells contributed to morbid 
weight gain. Interestingly, our HFD-fed BK
L1/L1 
mutants did not exhibit any changes in dietary 
food consumption or body temperature (Suppl. Fig. 1C+D), whereas the respective fat-cell 
specific mutants exhibited a lean phenotype that was related to an increase in UCP1 levels and 
energy expenditure (Fig. 7). It therefore seems tempting to speculate that BK channels in the 
brain or other non-fat cells dot no play a role for the chemical and neural signals regulating 
calorie intake and/or energy expenditure and thereby body composition. For several reasons, 
however, we find it is too early to draw such conclusions:  
i.) Our previous analyses of the global BK
L1/L1
 mouse model revealed multiple defects in 
various systems of these animals including in β-cells (15), the HPA-axis (14) and cerebellar 
neurons (29), which separately or together could affect energy balance and BW development. 
For example, lack of cerebellar BK channels in Purkinje cells, among other deficits, was 
shown to cause motor learning impairment and signs of ataxia with the latter being related to 
muscle shivering and trembling (29), a common cause for increased energy expenditure. 
Irrespective of the dietary fat content we did not observe an increase in the body core 
temperatures of BK
L1/L1 
mice (Suppl. Fig. 1D) suggesting that their very low body-fat content 
(Fig. 1) allow them to keep body temperature at physiological levels. Potential changes in 
body temperature regulation i.e. adjustments due to changes in non-/shivering thermogenesis 
may be superimposed by the loss of heat in BK
L1/L1
 mutants. Yet, BK
L1/L1
 mice present with a 
lean phenotype with CD and HFD feeding regimes and we observed a lower propensity of the 
BK/ob double mutants to accumulate excessive body weight and fat mass. This suggests that 
the global lack of BK channels for the entire lifespan prevents the excessive BW gain, an 
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effect that was more obvious in the presence of genetic or nutritional risk factors for obesity 
development. In this complex mouse model, a dysregulation of multiple pathways (in fat 
cells, hypothalamus, liver, sympathetic neurons, β-cells, etc.) involving BK may be related to 
this phenotype. 
ii.) The protection in terms of BW gain and fat accumulation was less pronounced in 
adipocyte specific BK knock-out groups as compared to the BK
L1/L1
 or BK/ob double mutant 
models (compare Fig. 1A, Suppl. Fig. 2A and Fig. 4F) implying non-fat cell BKs are also 
important for weight control in vivo. Indeed, dietary-related changes in energy expenditure 
involving, for example, hypothalamic control mechanisms may be positively or opposingly 
regulated by BK channels of neuronal nuclei that respond to satiety or hunger signals. Lack of 
GIRK4, a G protein-gated inwardly rectifying K
+
-channel, in mice, for instance, resulted in 
late onset obesity through hypothalamic mechanisms (31), whereas ATP-sensitive K
+
 channel 
(KATP) knock-out mice showed hyperphagia but were resistant to HFD induced BW and 
visceral fat mass gain (32). Along these lines, KATP conductance in diet-induced obesity has 
been reported in pro-opiomelanocortin positive nuclei of the hypothalamus, and neuronal 
excitability and thereby the release of peptides that control food intake and BW were sensitive 
to central KATP inhibition (33). In addition to KATP, BK channels have been shown to modulate 
the excitability of hypothalamic neurons in response of insulin and leptin under physiological 
conditions (34) suggesting they may be involved in central circuits regulating BW via energy 
intake and expenditure. Given the complexity of the different metabolic pathways future 
studies are needed to clarify the functional roles of hypothalamic and other non-fat cell BK 
channels in adiposity and thereby the mechanism(s) underlying the lean phenotype of BK
L1/L1
 
mice. Resistance to genetic and diet-induced models of obesity i.e. hypothalamic-driven 
obesity has also been reported in mice with a Shaker family voltage-dependent K
+
 channel 
gene disruption in Kv1.3 (35; 36), further highlighting the importance of K
+
 channels for the 
hypothalamic-regulation of BW (37). More recently, however, therapeutic benefits on obesity 
and insulin resistance upon Kv1.3 inhibition by using a blocker which was unable to cross the 
blood–brain barrier have been attributed to peripheral mechanisms stemming from changes in 
liver and WAT metabolism and brown adipose tissue (38). Obviously, peripheral and central 
K
+
-channels affect the development of adiposity.  
Studying adipocyte-specific BK knockout mice, we did not find any evidence for tamoxifen-
induced recombination in different brain regions including the hypothalamus and other tissues 
involved in total body metabolism such as muscle or liver (Fig. 3) suggesting that partial 
protection from diet-induced obesity (Fig. 4F) is resulting from the lack of BK channels in 
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adipocytes (Fig. 3). Further, we observed amplified BK expression and currents with 
adipogenic differentiation of both mouse adipocytes from eWAT fat cell precursors as well as 
in the pre-adipocyte 3T3-L1 cell line (Fig. 2K and Suppl. Fig. 4C). Pharmacological blockade 
of BK channels stimulated both growth and lipid incorporation supporting a role of BK 
channels as regulators of cell cycle progression in human pre-adipocytes (7). By assessing 
BK-deficient
 
eWAT and iWAT derived pre-adipocytes in vitro, however, we recognized fat 
depot specific functions for endogenous BK channels potentially involved in control of cell 
growth and lipid accumulation (Fig. 2). Because adiposity is usually induced through 
hypertrophic expansion of existing adipocytes leading to dysfunctional cells, an increase in 
the number of fat cells i.e. hyperplasia is proposed as mechanism that preserves metabolic 
fitness (39). Accordingly, lower levels of the pro-inflammatory cytokine IL-6 (Fig. 6D+E), 
significantly lower body weight (Fig. 4F), and smaller iWAT cell size together support the 
notion that lack of BK leads to the production of more “healthy” adipocytes that may afford 
protection against excessive BW gain thereby maintaining a regular response to the action of 
insulin. Reportedly, adipocytes produce and release IL-6 (40). In obesity the fraction of 
adipose-tissue derived IL-6 may promote a chronic state of low-grade inflammation affecting 
metabolism and development of insulin resistance (41). In comparison to adipoqBK
L1/L2 
mutant mice we find higher IL-6 adipose tissue mRNA (p < 0.05) and non-significantly 
elevated serum levels (p = 0.11) in HFD-fed adipoqBK
+/L2 
control mice, hence, it appears that 
fat cell BK channel activity is positively related to the adipose tissue IL-6 pathway providing 
a link between BK and obesity-related co-morbidities such insulin resistance (Fig. 6D+E and 
H). Interestingly, high plasma and adipose tissue levels of IL-6 were previously reported for 
the ob/ob mouse model (42), suggesting that BK channels may interfere with both, the 
genetic- and dietary-induced causes of adiposity by an IL-6-dependent mode of action. Along 
the same lines, HFD over-nutrition of adipoqBK
L1/L2 
mice revealed lower total fat mass and 
smaller fat cells in iWAT depots. Of note, iWAT cells and depots differed in size and mass 
only in vivo (Fig. 6), whereas in pre-/adipocyte cultures originating from iWAT pads we did 
not detect differences in terms of various adipogenic parameters (Fig. 2). The reason for this 
apparent discrepancy is unclear although several mechanisms could be involved. First, in vivo 
the adipocyte-specific lack of BK channels results in a decrease of the iWAT but not eWAT 
depot fat mass. A “normal” mass of the adipoqBK
L1/L2 
eWAT depot in vivo (Fig. 5A+C) may 
result from direct effects of the BK on the lipid storage and cell growth capacities and both 
parameters were augmented in the respective BK
L1/L1
-derived fat cells in vitro (Fig. 2A-C and 
G+H). In contrast, a lower eWAT depot mass in the global BK knockouts (Fig. 1D) may 
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result from dysregulation of BK-dependent mechanisms in non-adipocytes. Interestingly, our 
observations in HFD-fed adipoqBK
L1/L2
 and adipoqBK
+/L2 
mice imply a small but significant 
increase of approx. 0.3°C in the body’s core temperature in the absence of fat cell BKs (Fig. 
7D), which indicates that these channels are involved in the thermogenic program of adipose 
cells. Presence of UCP1 in iWAT is characteristic of a process known as browning where this 
depot acquires brown adipocyte-like catabolic functions (43), and we find the adipocyte-
specific ablation of BK channels to result in elevated mRNA (data not shown) and protein 
levels of iWAT UCP1 (Fig. 7A-C). Burning of stored fats by expansion or activation of BAT 
or by browning of WAT may result in a metabolically favorable phenotype (44). Accordingly, 
we observed a large fraction of smaller fat cells in iWAT, lower iWAT and total fat depot 
weights as well as an improved glucose homeostasis and insulin sensitivity in HFD-fed 
adipoqBK
L1/L2 
mice (Fig. 7A-C and H-J). 
Clearly, the mechanistic details underlying the lean phenotype of HFD-fed adipoqBK
L1/L2 
mutants require future investigation. In general, it is widely accepted that BK channels are 
activated either by a raise in intracellular Ca
2+
 ([Ca
2+
]i) or by membrane depolarization. 
[Ca
2+
]i dynamics have a multifaceted role for brown adipocyte-like functions and for the 
formation of mature fat laden adipocytes (45-52), however relatively little is known about 
Ca
2+
 signaling in white and brown adipocytes despite its suggested importance (53). Yet, 
efflux of K
+
 via BK in non-excitable cells such as adipocytes may serve as a positive 
regulator for Ca
2+
-entry as well as a number of Ca
2+
-dependent processes, whereas in 
excitable cells BK is usually part of a negative feedback loop limiting influx of Ca
2+
 via 
voltage-dependent Ca
2+
 channels (54). Recently, transient receptor potential vanilloid 4 
(TRPV4) channels have been identified as a major feature of the influx of extracellular Ca
2+
 
into fat cells (55). TRPV4 appears to negatively regulate the thermogenic and 
proinflammatory programs in adipocytes and mice with a TRPV4 ablation were protected 
from diet-induced obesity, hence TRPV4 deficiency results in a phenotype very similar to that 
caused by adipocyte-specific BK ablation. A functional coupling of BK and TRPV4 was 
reported in different systems (56; 57). Although this paper did not examine this link, we 
hypothesize that BK may suppress the acquisition of brown adipocyte-like features in white 
fat cells by an effect on the Ca
2+
-entry and subsequent signaling pathways involving TRPV4 
or other Ca
2+
-permeable members of the large TRP channel protein family (50; 51; 58).  
Finally, BK channels are common targets of various intracellular signaling molecules 
including cyclic guanosine-3´,5´-monophosphate (cGMP) and cyclic adenosine-3´,5´-
monophosphate (cAMP) (59; 60). It is well established that both, cAMP and cGMP pathways, 
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play, among others processes, differential roles in lipolysis, browning of WAT and brown fat 
cell thermogenesis (44; 61), which should allow for complex adjustments of BK function in 
the different fat depots in vivo under patho-/physiological conditions.  
Together, the presented data show that loss of fat cell BK channels supports the browning of 
fat cells to enhance thermogenesis in response to nutritional excess thereby limiting excessive 
weight gain. Targeting fat cells with BK channel inhibitors may thus hold potential to reduce 
pathologic features of excessive weight gain and related disorders. 
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Figure Legends 
 
Figure 1: Global lack of BK channels protects from overwhelming body weight (BW) 
gain and excessive fat accumulation. 
(A) Body weight (BW) increase of BK
+/+
 (blue) and BK
L1/L1
 (red) mice that received a control 
diet (CD) (n=12-14 mice per time-point; open data points) or 45% high-fat diet (HFD) (n=23-
25 mice per time-point, filled data points) for 18 weeks. (B) Body-composition of BK
+/+
 and 
BK
L1/L1
 mice after 18 weeks of dietary feeding was analyzed using the Soxhlet extraction 
method (n=4-7 mice per genotype). Representative images of (C) BK
+/+ 
and BK
L1/L1 
mice after 
18 weeks of CD- or HFD dietary feeding. (D) Fat mass of different white (WAT) and brown 
(BAT) adipose tissue depots of BK
+/+
 and BK
L1/L1
 mice fed either a CD (n=6-9 mice per fat 
depot) or HFD (n=9-16 mice per fat depot). Fat masses were normalized to tibia length 
(Suppl. Fig. 1F) to overcome growth differences between BK
+/+
 and BK
L1/L1
 mice that are not 
related to gain of body adiposity. Relative mRNA-expression of the BK-channel alpha subunit 
in (E) epididymal WAT (eWAT) and (F) subcutaneous inguinal WAT (iWAT) of 10 week 
old BK
+/+ 
and BK
L1/L1
 mice. Glyceraldehyde-3-phosphate dehydrogenase mRNA levels were 
used as a reference to normalize the data, which are presented as means ± SEM. Statistical 
difference between the two genotypes is indicated by * P<0.05, ** P<0.01. Representative 
cryo-sections of (G) eWAT and (H) iWAT stained for the BK alpha-subunit (upper panels) 
using a specific BK channel antibody. As negative control frozen tissue sections without the 
primary BK antibody were processed (lower panels). (G, H) Scale bars represent 200 µm. 
Data were analyzed using the 2-way ANOVA test (A) or Student‘s t-test (B, D-F) and are 
presented as means ± SEM. Statistical difference between the two genotypes is indicated by  
* P<0.05, ** P<0.01, *** P<0.001. Abbreviations used: Epididymal WAT (eWAT); 
interscapular WAT (intWAT); interscapular BAT (intBAT); mesenteric WAT (mesWAT); 
subcutaneous inguinal WAT (iWAT).  
 
Figure 2: Accelerated growth of BK-negative epididymal WAT (eWAT)-derived pre-
adipocytes. 
Representative Oil-red-O (ORO) staining of eWAT-derived pre-adipocytes in (A) high 
magnification and (B) as overviews screen after 14 days of adipogenic differentiation 
revealing higher numbers of mature adipocytes in BK
L1/L1
 in comparison to BK
+/+ 
cells. (C) 
The increased adipogenic potential in BK
L1/L1
 (red) was confirmed by analyzing ORO-
incorporation quantitatively at 518 nm (n=3 independent in vitro assays per genotype). (D, E) 
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Representative ORO staining of inguinal WAT (iWAT)-derived pre-adipocytes after 14 days 
of adipogenic differentiation. Scale bars (A, D) represent 100 µm. (E, F) Based on the ORO-
incorporation assay maturation of iWAT-derived BK
+/+ 
and BK
L1/L1
 pre-adipocytes was not 
different between the genotypes (n=7-8 independent in vitro assays per genotype). (G) 
Representative growth of eWAT-derived pre-adipocytes examined in real-time using an 
impedance-based setup. Lack of BK channels (red) in eWAT-derived pre-adipocytes resulted 
in accelerated growth properties at different cell concentrations tested as compared to wild-
type cells (blue). (H) A pharmacological approach to block the BK channel using 1 µM 
paxilline confirmed the BK-dependent growth capacity of eWAT-derived pre-adipocytes. (I) 
Up-regulation of GLUT4 and BK channel mRNA and (J) protein levels following 
differentiation of eWAT murine pre-adipocytes (pre-adipo) to adipocytes (adipo) (n=3 
independent experiments per group). (K) Pre-adipocyte cells display a small paxilline-
sensitive (1 µM) outward whole-cell BK potassium current determined under physiological 
potassium gradients (n=8 cells) that was significantly increased upon adipogenic 
differentiation for 14 days (n=12 cells). 
 
Figure 3: Spatiotemporal ablation of fat cell BK channels using the adipoqCreERT2
tg/+
 
recombination system. 
Recombination efficiency was determined by a change from red (Cy3-channel) to green 
(FITC-channel) fluorescence using the ROSA26-Tomato
tom/+
 (tom/+) Cre-reporter mouse line. 
(A) Analysis of eWAT and (B) subcutaneous iWAT derived from double-transgenic 
adipoqCreER
tg/+
;
 
ROSA26-Tomato
tom/+
 (tg/+; tom/+) mice with or without tamoxifen (TAM) 
injections in comparison to wildtype age-matched littermate male control mice (+/+; +/+). (C) 
Genomic PCR-analysis of the adipoqCreERT2
tg/+
-mediated recombination of the pre-mutant 
BK gene locus in different tissues. PCR products amplified from the loxP-flanked (L2 allele 
with two loxP sites; two black triangles flanking a closed box), wild type (+ allele; closed 
black box), and knock-out (L1 allele with one loxP site; one black triangle) alleles of 
representative adipoqCreERT2
tg/+
; BK
+/L2
 (adipoqBK
+/L2
) animals. Conversion of the loxP-
flanked L2 allele to the L1 allele was only observed in fat cell depots after injecting tamoxifen 
(+), whereas with saline (-) treatment we did not find evidence for unspecific Cre activity. 
Recombination was analyzed 14 days after the beginning of tamoxifen or saline injections in 
10 weeks old mice. The size of the PCR amplicons were 577 bp, 466 bp and 132 bp for the 
floxed, WT and knockout allele, respectively. Abbreviations used: Pancreas (P); liver (L); 
hypothalamus (H); bulb (B); cerebellum (C); rest of brain (Br); heart (He); skeletal muscle 
Page 59 of 76
For Peer Review Only
Diabetes
Illison et al. Adipocyte BK protects from overwhelming BW gain 07/24/2016 
29 
 
(S); duodenum (D); epididymal white adipose tissue (eWAT); subcutaneous inguinal white 
adipose tissue (iWAT) and brown adipose tissue (BAT); marker (M). (D) Quantitative mRNA 
analysis of the BK mRNA in eWAT and iWAT of TAM-injected adipoqCreER
tg/+
; BK
+/L2
 
control mice (n= 5 for eWAT and iWAT) and age and littermatched adipoqCreER
tg/+
; BK
L1/L2 
tissue-specific mutants n= 7 for eWAT and n=4 iWAT). Analysis of the frequency and 
distribution of the adiponectin-CreERT2-mediated recombination after TAM injections in (E) 
eWAT and (F) iWAT of adipoqCreER
tg/+
; BK
+/L2 
(adipoqBK
+/L2
) and
 
adipoqCreER
tg/+
; 
BK
L1/L2 
(adipoqBK
L1/L2
) mice using a specific BK channel antibody (+anti-BK; upper panels). 
A parallel analysis of serial eWAT and iWAT sections from both genotypes was performed to 
establish the background fluorescence in the absence of BK-specific antibodies (-anti-BK; 
lower panels). Scale bars represent 50 µm. 
 
Figure 4: Reduced BW gain in adipoqBK
L1/L2
 mice receiving a 60% HFD feeding. 
(A) Control diet (CD) feeding protocol. Male adipoqCreER
tg/+
; BK
L1/L2
 (adipoqBK
L1/L2
) and 
adipoqCreER
tg/+
; BK
+/L2
 (adipoqBK
+/L2
) were injected prior to the dietary feeding with 
tamoxifen (TAM) for 5 consecutive days at an age of 8 weeks, which induced a specific and 
efficient ablation of the BK channel in various adipose tissues (see also Fig. 3). Upon 2 weeks 
of adaption to the CD, CD diet feeding was continued or (B) mice revived a HFD for 18 
weeks (prevention study). In an alternative approach additional groups of adipoqBK
L1/L2 
and 
adipoqBK
+/L2 
mice were subjected to the same feeding protocol, but tamoxifen was injected at 
an age of 19 weeks (TAM19) when over-weight has already been established. Food intake of 
adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice were analyzed, using modified metabolic 
cages as described in the methods section either (C) at the beginning (n=4-6 mice per 
genotype) or (D) at the end of the respective dietary feeding (n=3-5 mice per genotype). BW 
development under (E) CD feeding (n=12-20 per genotype/time-point) and (F) HFD feeding 
(n=24-29 mice per genotype/time-point). Difference (∆BW) between the initial BW (at week 
10) and the BW at week 30 in adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice under (G) 
CD and (H) HFD feeding conditions (n=12-15 per genotype for CD, n=24-26 per genotype 
for HFD). (I) Tamoxifen was injected for 5 consecutive days at an age of 19 week when a 
HFD-induced BW gain in adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
(blue) mice was already 
established to test the therapeutic potential of WAT BK inactivation (n=17-22 mice per 
genotype/time-point). The final BW between the two genotypes was significantly different (* 
P<0.05). 
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Figure 5: Reduced fat accumulation and smaller fat depots in adipoqBK
L1/L2 
mice fed a 
60% high-fat diet (HFD).  
Mass of different white (WAT) and brown (BAT) adipose tissue  depots of male 
adipoqBK
L1/L2 
(red) and adipoqBK
+/L2 
 (blue) mice examined after 18 weeks of (A) control 
diet (CD) or (B) HFD feeding (n=12-15 per genotype for CD, n=24-26 per genotype for 
HFD). Body-composition of adipoqBK
+/L2 
 and adipoqBK
L1/L2 
at an age of 30 weeks (C) after 
CD and (D) after HFD feeding. Total body fat was extracted using the soxhlet extraction 
method (n=3 per genotype for CD, n=4-7 per genotype for HFD). (E-G) Representative 
pictures of adipoqBK
+/L2
 and adipoqBK
L1/L2 
mice and selected fat depots after 18 weeks on 
CD. (E) View from back, (F) front view with opened abdominal cavity and (G) magnification 
of BAT, eWAT and iWAT. All data were analyzed using the Student‘s t-test and are 
presented as means ± SEM (* P<0.05). (E-G) Scale bars represent 2 cm. Abbreviations used: 
Epididymal WAT (eWAT), interscapular WAT (intWAT), interscapular BAT (intBAT), total 
interscapular adipose tissue  (intAT), mesenteric WAT (mesWAT), subcutaneous inguinal 
WAT (iWAT) and total investigated adipose depots (total). 
 
Figure 6: Fat cell hyperplasia and improved glucose handling in adipoqBK
L1/L2
 mice.  
(A) Average cell size of inguinal WAT (iWAT) of male adipoqBK
+/L2 
 and adipoqBK
L1/L2 
 
mice after 18 weeks of HFD was examined in serial cryo-sections by measuring the 
circumference of cells in central and peripheral regions of the respective depots. (B) 
Classification of average cell sizes (as an indicator of adipose cell number) in adipoqBK
+/L2 
 
and adipoqBK
L1/L2 
 iWAT, prior diet (PD) and after 18 weeks of control diet (CD) or 60% 
high-fat diet (HFD) feeding. (C) Representative cryo-sections of iWAT derived from 
adipoqBK
+/L2 
 (blue) and adipoqBK
L1/L2 
 (red) PD or after either 18 weeks of CD or HFD. 
Scale bars represent 100 µm. Relative (D) mRNA-expression and (E) serum levels of 
interleukin-6 (IL-6) a marker for adipose tissue inflammation and serum levels of (F) 
adiponectin and (G) leptin determined after 18 weeks of CD (open bars) and/or HFD (closed 
bars) feeding in adipoqBK
+/L2 
 (blue) and adipoqBK
L1/L2 
 (red) mice. Blood-glucose (BG) 
levels were monitored before as well as 15, 30, 60 and 120 minutes after i.p. injection of 2 
g/kg glucose (H) after 18 weeks of HFD-feeding and (I) prior the respective diet. (J) Plasma 
insulin levels at baseline (0 min) and during the intraperitoneal glucose-tolerance-test (15 to 
120 min post injection) in adipoqBK
L2/+
 (blue, n=6) and adipoqBK
L1/L2
 (red, n=8) mice after 
18 weeks of HFD-feeding. All data (A, D-J) were examined using the Student‘s t-test and are 
presented as means ± SEM (* P<0.05, ** P<0.01). 
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Figure 7: Increased UCP1 levels and body temperature in HFD-fed adipoqBK
L1/L2 
mice 
(A) UCP1 expression analysis (brown staining in left panels) in frozen tissue sections derived 
from HFD-fed adipoqBK
+/L2
 and adipoqBK
L1/L2
 iWAT. As negative control sections derived 
from the same fat pads were processed in the absence of the primary UCP1 antibody (right 
panels). (B) Representative UCP1immunoblot of iWAT protein lysates derived from HFD-fed 
adipoqBK
+/L2
 and adipoqBK
L1/L2
 mice. Equal loading of the gel was verified by co-detection 
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (C) Quantification of the 
immunoblot data shown in (B). UCP1 protein levels were normalized to the expression of 
GAPDH in adipoqBK
+/L2
 (closed blue bars; n=3) and adipoqBK
L1/L2
 (closed red bars; n=4) 
iWAT samples. (D) Telemetric sensors were used to measure the body core temperature of a 
subset of adipoqBK
+/L2
 and adipoqBK
L1/L2
 mice that received the HFD-feeding. All data (C, 
D) were assessed using the Student‘s t-test and are presented as means ± SEM. * P<0.05, ** 
P<0.01. 
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Suppl. Figure Legends 
 
Suppl. Fig. 1: Change in (A) absolute and (B) percental body weight (BW) of global BK-
deficient (BKL1/L1; red) and wild-type (BK+/+; blue) mice after 18 weeks of CD- (open bars) or 
HFD-feeding (filled bars). (C) CD and HFD food intake and (D) body core temperature, (E) 
activity and (E) tibia length of HFD-fed BK+/+ and BKL1/L1 at an age of 30 weeks. All data 
were evaluated using the Student‘s t-test and are presented as means ± SEM. Statistical 
difference between the two genotypes is indicated by ** P<0.01 or *** P<0.001. 
 
Suppl. Fig. 2: (A) BW gain of BK+/+; ob/ob (n=19-22 mice per time-point, filled blue data 
points) and BKL1/L1; ob/ob (n=11-18 mice per time-point, filled red data points) as well as the 
respective lean control littermates (Lep +/+; n=15-19 mice per time-point, open red or blue 
data points) fed a normal chow diet. (B) Body-composition of BK+/+; ob/ob and BKL1/L1; 
ob/ob mice at an age of 24 weeks was analyzed using the Soxhlet extraction method (n=4-5 
mice per genotype). (C) Representative images of BK+/+; ob/ob and BKL1/L1; ob/ob mutants 
and their respective lean control littermates after a normal chow diet at an age of 24 weeks. 
(D) BK+/+; ob/ob (n=17) and BKL1/L1; ob/ob mice (n=13) and their lean control littermates (n= 
9-12) fed a normal chow diet at an age of 24 weeks. Fat masses were normalized to tibia 
length (Suppl. Fig. 2E) to overcome the growth differences between the different BK 
genotypes that are not related to gain of body adiposity. Data were analyzed using the 2-way 
ANOVA test (C) or Student‘s t-test (B, D) and are presented as means ± SEM. Statistical 
difference between the two genotypes is indicated by * P<0.05, ** P<0.01, *** P<0.001. (E) 
Tibia length of male double-mutant BKL1/L1; ob/ob (filled red bar; n=13) and BK+/+; ob/ob 
control mice (filled blue bar; n=17) as well as lean BKL1/L1; Lep +/+ (open red bar; n=12) and 
BK+/+; Lep +/+ control mice (open blue bar; n= 9) at an age of 24 weeks. As expected, TL 
measurements confirm that the BK negative ob/ob and Lep +/+ mice are smaller than their 
respective BK+/+ controls. This difference, however, did not reach statistical significance for 
the lean groups. Number signs (#) indicate significant difference between BKL1/L1; ob/ob and 
BKL1/L1; Lep +/+ mice suggesting that BK/ob influence each other in a complex manner. All data 
were evaluated using the Student‘s t-test and are presented as means ± SEM. Statistical 
difference is indicated by ***/### P<0.001.  
 
Suppl. Fig. 3: (A) Epididymal white adipose tissue (eWAT) BK mRNA expression in BK 
wild-type (BK+/+; n=6) and knock-out (BKL1/L1; n=4) mice. Plus (+) reverse transcriptase (RT) 
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indicates samples for the quantification of BK mRNA levels. Minus (-) RT samples were 
analyzed in parallel in the absence of RT. (B) BK mRNA expression in inguinal WAT 
(iWAT) depot of BK+/+ (n=5) and BKL1/L1 (n=5) mice. (C) Immunohistochemical staining for 
BK (left panel) and hormone sensitive lipase (HSL; central panel) in cryosections of eWAT 
derived from BK+/+ and BKL1/L1 mice using 3,3'-Diaminobenzidine as a chromogen. Negative 
control staining without primary BK antibodies were processed in parallel and did not reveal a 
specific staining (right panel) in BK+/+ or BKL1/L1 eWAT. Scale bar = 200 µm. All data were 
evaluated using the Student‘s t-test and are presented as means ± SEM. Statistical difference 
between genotypes is indicated by * P<0.05, ** P<0.01, *** P<0.001. 
 
Suppl. Fig. 4: Upregulation of GLUT4 and BK channel (A) mRNA and (B) protein levels 
following differentiation of 3T3-L1 fibroblasts (pre-adipo) to adipocytes (adipo) (n =3/4 
independent experiments per group). (C) Pre-adipo 3T3-L1 cells display no significant 
paxilline-sensitive (1µM) outward whole-cell BK potassium current determined under 
physiological potassium gradients (white; n = 8 cells). In contrast, paxilline-sensitive outward 
current was significantly increased in differentiated 3T3-L1 cells (black; n = 12 cells). (D) 
Inhibition of BK channels with paxilline (Pax) increased growth of differentiating 3T3-L1 
cells (n = 4/group) compared to vehicle control (Ctr) and (E) increased adipogenic potential 
following 14 days of differentiation as determined by Oil-red-O (ORO) incorporation (n = 
4/group). Data are Means ± SEM. * p<0.05 ANOVA with post-hoc Dunnett’s test. 
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